Metrics
Publication
296
Open Access
34
UN Sustainable Development Goals
Announcements & Documents
Download File
Education
2006 - 2010
2006 - 2010Post Doctorate of Medicine
Gazi University, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Turkey
1997 - 2006
1997 - 2006Expertise In Medicine
Gazi University, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Turkey
1991 - 1997
1991 - 1997Undergraduate
Ankara University, Tıp Pr., Turkey
Dissertations
2010
2010Post Doctorate of Medicine
Mültipl myelomda yüksek doz kemoterapi ve otolog hematopoetik kök hücre nakli ile tedavide serum serbest hafif zincir düzeylerinin prognostik anlamı
Gazi University, Tıp Fakültesi
2002
2002Expertise In Medicine
Diyaliz tedavisi alan hastalarda aterosklerotik risk faktörlerinin karotis aterosklerozu ile korelasyonu
Gazi University, Tıp Fakültesi
Research Areas
Avesis Research Areas:
Health Sciences
WoS Research Areas:
Clinical Medicine (Med)
Research Areas Based on Academic Activities
Avesis Research Areas
WoS Research Areas
Scopus Research Areas
Academic Positions
2018 - Present
2018 - PresentProfessor
Gazi University, Tıp Fakültesi, Dahili Tıp Bilimleri
2012 - 2018
2012 - 2018Associate Professor
Gazi University, Tıp Fakültesi, Dahili Tıp Bilimleri
2009 - 2010
2009 - 2010Lecturer
Gazi University, Tıp Fakültesi, Dahili Tıp Bilimleri
2006 - 2009
2006 - 2009Research Assistant PhD
Gazi University, Tıp Fakültesi, Dahili Tıp Bilimleri
2003 - 2006
2003 - 2006Assistant Professor
Kirikkale University, School Of Medıcıne, Department Of Internal Medıcıne
1997 - 2002
1997 - 2002Research Assistant PhD
Gazi University, Tıp Fakültesi, Dahili Tıp Bilimleri
Managerial Experience
2013 - Present
2013 - PresentFarabi Program Institutional Coordinator
Gazi University, Tıp Fakültesi
2022 - 2025
2022 - 2025Head of Department
Gazi University, Tıp Fakültesi, Dahili Tıp Bilimleri
Non Academic Experience
2010 - 2012
2010 - 2012HEMATOLOJİ UZMANI
KAHRAMANMARAŞ DEVLET HASTANESİ, HEMATOLOJİ UZMANI
2002 - 2003
2002 - 2003İÇ HASTALIKLARI UZMANI
MİLLİ EĞİTİM BAKANLIĞI BEŞEVLER SAĞLIK EĞİTİM MERKEZİ, İÇ HASTALIKLARI UZMANI
Supervised Theses
2024
2024Expertise In Medicine
Multipl Miyelom Tanılı Hastalarda Ekstramedüller Hastalık Tutulumunun Prognoz ve Sağkalım Üzerine Etkisinin Değerlendirilmesi
Özkurt Z. N. (Consultant)
S.KANBER(Student)
2023
2023Expertise In Medicine
Allojenik kök hücre nakli yapılan hastalarda steroide yanıtsız gastrointestinal graft versus host hastalığı risk faktörlerinin belirlenmesi ve tedavi seçeneklerinin değerlendirilmesi
Özkurt Z. N. (Consultant)
K.TALAY(Student)
2022
2022Expertise In Medicine
Akut lösemi tanılı allojenik kök hücre nakli yapılan hastalarda hepatik veno-okluzif hastalık sıklığı ve risk faktörleri
Özkurt Z. N. (Consultant)
E.AREL(Student)
2020
2020Expertise In Medicine
Yeni tanı multipl myelomlu hastalarda indüksiyon tedavisi ile değişen performans, geriatrik değerlendirme ve kırılganlık testi sonuçlarının analizi
ÖZKURT Z. N. (Consultant)
K.DURMUŞ(Student)
2019
2019Expertise In Medicine
The Effect Of Comorbidity Scores And Geriatric Tests On The Results Of Autologous Stem Cell Transplantation Recipients
Özkurt Z. N. (Consultant)
M.KESTANE(Student)
2018
2018Expertise In Medicine
Toxicity of maintenance therapy in adult Acute Lymphoblastic Leucemia and evaluating effect of toxicity on survival outcomes, Gazi University Faculty of Medicine, Thesis in Internal Medicine
Özkurt Z. N. (Consultant)
M.ECEM(Student)
2015
2015Expertise In Medicine
Analysis of The Factors Associated With Mobilization Success in Allogeneic Stem Cell Donors
ÖZKURT Z. N. (Consultant)
L.BATMAZ(Student)
Articles
All (129)
SCI-E, SSCI, AHCI (102)
SCI-E, SSCI, AHCI, ESCI (113)
ESCI (9)
Scopus (111)
TRDizin (35)
Other Publications (1)
2026
20261. Is Consolidation Therapy Effective in Multiple Myeloma Patients after High-Dose Chemotherapy and Autologous Stem Cell Transplantation: Single Center Real-Life Data with Cyclophosphamide-Bortezomib-Dexamethasone or Bortezomib-Lenalidomide-Dexamethasone?
Yildiz S., DEMİREZEN A., YEGİN Z. A., YAĞCI A. M., ÖZKURT Z. N.
INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION
, vol.42, no.3, pp.765-772, 2026 (SCI-Expanded, Scopus)
2026
20262. Prognostic Value of APACHE II, SAPS II, and SOFA Scores in Critically Ill Hematologic Patients: A Single-Center, Retrospective Analysis
AKCAN E., AYGENCEL BIKMAZ Ş. G., İNCİ K., Dundar N. B., TÜRKOĞLU M., ŞEYHANLI A., et al.
Journal of Critical and Intensive Care
, vol.17, no.1, pp.11-19, 2026 (ESCI, Scopus, TRDizin)
2026
20263. The Impact of Donor Hematological Parameters on Early Donor Complications: A Multicenter Donor Research Team Project
Aydın M. S., Yıldız Ş., YEGİN Z. A., ÖZKURT Z. N., YAVAŞOĞLU F., İLHAN Ç., et al.
Indian Journal of Hematology and Blood Transfusion , vol.42, no.1, pp.207-212, 2026 (SCI-Expanded, Scopus)
2025
20254. Frequency of NPM1 Mutation and Its Impact on Prognosis in Cytogenetically Normal AML Patients: Hyperleukocytosis Remains an Unfavorable Prognostic Marker Among NPM1 Positive Patients
Pepeler M. S., Özkurt Z. N., Kaya A., Gökçen S., Sunguroğlu A., Kayhan H., et al.
Acta haematologica oncologica Turcica
, vol.58, no.3, pp.190-195, 2025 (TRDizin)
2025
20255. Day + 100 bone marrow megakaryocyte count predicts transplant outcome in patients with high-risk myelodysplastic syndrome and acute leukemia
YEGİN Z. A., Yıldız Ş., Savaş E. M., ŞEKER A., UYAR GÖÇÜN F. P., ÖZKURT Z. N., et al.
Journal of Hematopathology , vol.18, no.1, 2025 (SCI-Expanded, Scopus)
2025
20256. Etiological Agents of Bacteremia in Patients with Hematological Malignancies: Evaluation of 18 Years of Data
ÖZGEN TOP Ö., AYSERT YILDIZ P., GÜÇLÜ F., ÖZKURT Z. N., YEGİN Z. A., YAĞCI A. M., et al.
Infectious diseases and clinical microbiology (Online) , vol.7, no.4, 2025 (ESCI, Scopus, TRDizin)
2025
20257. C-Reactive Protein/Albumin Ratio (CAR) Predicts Early Posttransplant Complications and Survival in Allogeneic Hematopoietic Stem Cell Transplantation Recipients
YILDIZ Ş., YEGİN Z. A., GÜNDEM G. G., Yaşar S., Çiçekli S., ÖZKURT Z. N., et al.
Indian Journal of Hematology and Blood Transfusion , vol.41, no.4, pp.800-808, 2025 (SCI-Expanded, Scopus)
2025
20258. COVID-19 Vaccine Response in Allo-HSCT Recipients: Insights from a Real-World Prospective Cohort Study
Savaş E. M., Yıldız Ş., ÖZKURT Z. N., BALTACI Z., GÜZEL TUNÇCAN Ö., YEGİN Z. A., et al.
Vaccines , vol.13, no.7, 2025 (SCI-Expanded, Scopus)
2025
20259. Comparative Analysis of Chemiluminescence Immunoassay (CLIA)-Based Tests in the Diagnosis of Invasive Aspergillosis in Patients With Hematologic Malignancies
Kılıç E., Şahin E. A., Tunçcan Ö., Yıldız Ş., Özkurt Z. N., Yeğin Z. A., et al.
MYCOSES
, vol.68, no.4, 2025 (SCI-Expanded, Scopus)
2024
202410. Hypomagnesemia May Predict Better Survival and Reduced Nonrelapse Mortality in Allogeneic Hematopoietic Stem Cell Transplantation Recipients.
Savaş E. M., Yegin Z. A., Kök M. İ., Karayel H. T., Özkurt Z. N., Bozer M. N., et al.
Transplantation proceedings , vol.56, no.2, pp.386-393, 2024 (SCI-Expanded, Scopus)
2024
202411. Thiotepa-Based Regimens Are Valid Alternatives to Total Body Irradiation-Based Reduced-Intensity Conditioning Regimens in Patients with Acute Lymphoblastic Leukemia: A Retrospective Study on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
Battipaglia G., Labopin M., Mielke S., Ruggeri A., Nur Ozkurt Z. N., Bourhis J. H., et al.
Transplantation and Cellular Therapy , vol.30, no.1, 2024 (SCI-Expanded, Scopus)
2024
202412. Ototoxicity associated with hematopoietic stem cell transplantation; what are the risk factors?
Uzunoglu E., Akalın M., Özkurt Z. N., Yegin Z. A., Karamert R.
ACTA OTO-LARYNGOLOGICA , vol.144, no.11-12, pp.615-619, 2024 (SCI-Expanded, Scopus)
2024
202413. Clinical factors associated with autologous stem cell transplantation outcomes in multiple myeloma: upfront transplant with MEL200 remains the standard of care.
Bostankolu Değirmenci B., Yegin Z. A., Akdemir Ü. Ö., Dede A., Gündem G. G., Özkurt Z. N., et al.
Annals of hematology , vol.103, no.1, pp.269-283, 2024 (SCI-Expanded, Scopus)
2023
202314. ECP versus ruxolitinib in steroid-refractory acute GVHD - a retrospective study by the EBMT transplant complications working party.
Penack O., Peczynski C., Boreland W., Lemaitre J., Afanasyeva K., Kornblit B., et al.
Frontiers in immunology
, vol.14, pp.1283034, 2023 (SCI-Expanded, Scopus)
2023
202315. Long-term Results of Imatinib Discontinuation in Patients with Chronic-phase Chronic Myeloid Leukemia: A National Multicenter Prospective Study.
Savaş E. M., Yılmaz S., Başer Dikyar A. A., Özkurt Z. N., Öcal R., Can F., et al.
Turkish journal of haematology : official journal of Turkish Society of Haematology
, vol.40, no.4, pp.236-241, 2023 (SCI-Expanded, Scopus, TRDizin)
2023
202316. Preconditioning Modified-Easix as a Predictor of Prognosis in Allogeneic Hematopoietic Stem Cell Transplant Recipients
YEGİN Z. A., SAVAŞ E. M., YILDIZ Ş., KÖK M. İ., ERDEMİR M. B., BOSTANKOLU DEĞİRMENCİ B., et al.
INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION , vol.39, no.4, pp.586-597, 2023 (SCI-Expanded, Scopus)
2023
202317. The Effect of Granulocyte Colony-Stimulating Factor (G-CSF) on Early Complications and Graft-Versus-Host Disease (GVHD) in Allogeneic Stem Cell Transplantation (ASCT) Recipients
Kaynar L. A., Oezkurt Z. N.
CUREUS JOURNAL OF MEDICAL SCIENCE
, vol.15, no.9, 2023 (ESCI)
2023
202318. Is flow cytometry useful in determining central nervous system involvement in patients with hematological malignancy? Analysis with a prospective cohort.
Kaynar L. A., Özkurt Z. N., Savaş E. M., Yeğin Z. A., Göçün P. U., Akyürek N., et al.
Leukemia research , vol.131, pp.107332, 2023 (SCI-Expanded, Scopus)
2023
202319. Comparison of maintenance regimens in Acute Promyelocytic Leukemia patients
Gunes E. K., ÖZKURT Z. N., YILDIZ Ş., Ozet G., Ceran F., Albayrak M., et al.
LEUKEMIA RESEARCH , vol.128, 2023 (SCI-Expanded, Scopus)
2023
202320. Safety and efficacy of autologous stem cell transplantation in dialysis-dependent myeloma patients-The DIADEM study from the chronic malignancies working party of the EBMT
Waszczuk-Gajda A., Gras L., de Wreede L. C., Sirait T., Illes A., ÖZKURT Z. N., et al.
BONE MARROW TRANSPLANTATION , vol.58, no.4, pp.424-429, 2023 (SCI-Expanded, Scopus)
2023
202321. The Turkish perspective on apheresis activity: The Turkish apheresis registry report
Ozatli D., Giden A. O., ERKURT M. A., Korkmaz S., Basci S., Ulas T., et al.
Transfusion and Apheresis Science , vol.62, no.2, 2023 (SCI-Expanded, Scopus)
2023
202322. [Comparison of the Results of Galactomannan and Beta Glucan Antigen Tests in the Suspicion of Invasive Pulmonary Aspergillosis].
Çuhadar T., Kalkancı A., Tunçcan Güzel Ö., Yeğin Z. A., Özkurt Z. N., Köktürk N., et al.
Mikrobiyoloji bulteni , vol.57, no.2, pp.274-282, 2023 (SCI-Expanded, Scopus, TRDizin)
2023
202323. Analysis of bone marrow samples by the SYSMEX-XN20 hematology analyzer
KAYA Z., Kirkiz S., ÖZKURT Z. N., YAĞCI A. M., KOÇAK Ü.
International Journal of Laboratory Hematology , vol.45, no.2, 2023 (SCI-Expanded, Scopus)
2023
202324. Effects of COVID-19 Infection on Patients with Hematological Malignancy
KAYNAR L. A., GÜZEL F. Ö., Dikyar A., Bostankolu Değirmenci B., BOZDAYI G., ERBAŞ G., et al.
Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları , vol.7, no.1, pp.14-19, 2023 (TRDizin)
2023
202325. COVID-19 Enfeksiyonunun Hematolojik Maligniteli Hastalar Üzerine Etkiler
AYDIN KAYNAR L., GÜZEL TUNÇCAN Ö., DİKYAR A., BOSTANKOLU DEĞİRMENCİ B., BOZDAYI G., ERBAŞ G., et al.
Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları , vol.7, no.1, pp.14-19, 2023 (TRDizin)
2023
202326. Opioid Administration for Mucositis-related-Pain Using Patient Controlled Analgesia (PCA) Method is Associated with the Development of Early Posttransplant Complications
gürün k., YEGİN Z. A., Akçalı D., ÖZKURT Z. N., tertemiz o., CAN F., et al.
ACTA ONCOLOGICA TURCICA , vol.56, no.2, pp.125-135, 2023 (TRDizin)
2023
202327. Risk factors for ICU mortality in patients with hematological malignancies: a single-center, retrospective cohort study from Turkey
AYGENCEL BIKMAZ Ş. G., Gökçe O., Haşimoğlu M., BOYACI DÜNDAR N., TÜRKOĞLU M., YEGİN Z. A., et al.
Turkish Journal of Medical Sciences , vol.53, no.1, pp.340-351, 2023 (SCI-Expanded, Scopus, TRDizin)
2023
202328. Salvage autologous hematopoietic stem cell transplantation versus chemoimmunotherapy in relapsed multiple myeloma patients after first transplantation, single center data
CAN F., ÖZKURT Z. N., ÖCAL R., YEGİN Z. A., AYDIN KAYNAR L., YAĞCI A. M.
Ankara Üniversitesi Tıp Fakültesi Mecmuası , vol.76, no.3, pp.200-205, 2023 (TRDizin)
2023
202329. Exercise capacity, physical activity and quality of life in patients with newly diagnosed hematologic malignancies: a cross-sectional study
ÇELİK Z., BOŞNAK GÜÇLÜ M., ÖZKURT Z. N.
PHYSIOTHERAPY THEORY AND PRACTICE , vol.39, no.6, pp.1152-1162, 2023 (SCI-Expanded, Scopus)
2022
202230. Is comprehensive geriatric testing guiding in the identification of multiple myeloma patients who are candidates for autologous stem cell transplantation? A prospective analysis
Demirel K. D., ÖZKURT Z. N., Dogrul R. T., Kaynar L. A., YEGİN Z. A., GÖKER B., et al.
ANNALS OF HEMATOLOGY , vol.101, no.12, pp.2691-2697, 2022 (SCI-Expanded, Scopus)
2022
202231. The impact of thrombopoietin receptor agonists on bone marrow fibrosis in allogeneic stem cell transplant recipients
Degirmenci B. B., Yegin Z. A., Dikyar A., Kaynar L. A., ÖZKURT Z. N., UYAR GÖÇÜN F. P., et al.
BONE MARROW TRANSPLANTATION , vol.57, no.SUPPL 1, pp.362-363, 2022 (SCI-Expanded, Scopus)
2022
202232. Haploidentical Versus Matched Sibling Donor Hematopoietic Stem Cell Transplantation for Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia: A Study From the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Nagler A., Labopin M., Swoboda R., Pioltelli P., Arat M., Yakoub-Agha I., et al.
HemaSphere , vol.6, no.11, 2022 (Scopus)
2022
202233. Maintenance Therapy Toxicities, MTHFR and TPMT Genetic Polymorphism Analysis, and the Effect of Dose Manipulations on Survival Outcomes in Adult Patients with Turkish Acute Lymphoblastic Leukemia
Erdoğan Yön M. E., Özkurt Z. N., Gökçen S., Öcal R., Yegin Z. A., Yağcı A. M.
Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları , vol.6, no.2, pp.29-37, 2022 (TRDizin)
2022
202234. Comparison of daily oral iron replacement therapy with every other day treatment in female reproductive age patients with iron-deficiency anemia
AYDIN KAYNAR L., GÖKÇEN S., Can F., YEGİN Z. A., ÖZKURT Z. N., Yagci M.
ANNALS OF HEMATOLOGY , vol.101, no.7, pp.1459-1464, 2022 (SCI-Expanded, Scopus)
2022
202235. Eltrombopag may induce bone marrow fibrosis in allogeneic hematopoietic stem cell transplant recipients with prolonged thrombocytopenia
BOSTANKOLU DEĞİRMENCİ B., YEGİN Z. A., DİKYAR A., AYDIN KAYNAR L., ÖZKURT Z. N., UYAR GÖÇÜN F. P., et al.
Leukemia Research , vol.118, 2022 (SCI-Expanded, Scopus)
2022
202236. Variable impact of graft CD3(+) cell content on graft versus host disease in hematopoietic stem cell transplant recipients: Is the role of donor CD3(+) cells overestimated?
YEGİN Z. A., BOSTANKOLU DEĞİRMENCİ B., YAZICI ŞENER G., SAVAŞ E. M., ÖZKURT Z. N., Koc H. N., et al.
TRANSFUSION AND APHERESIS SCIENCE , vol.61, no.3, 2022 (SCI-Expanded, Scopus)
2022
202237. Autologous hematopoietic cell transplantation for relapsed multiple myeloma performed with cells procured after previous transplantation-study on behalf of CMWP of the EBMT
Drozd-Sokolowska J., Gras L., Zinger N., Snowden J. A., Arat M., Basak G., et al.
BONE MARROW TRANSPLANTATION
, vol.57, no.4, pp.633-640, 2022 (SCI-Expanded, Scopus)
2022
202238. Standart Prophylactic Granulocyte Colony Stimulating Factor Usage as a Part of Autologous Stem Cell Transplantati̇ on Procedure
AYDIN KAYNAR L., ÖZKURT Z. N., CAN F., YEGİN Z. A., GÜZEL TUNÇCAN Ö., YAĞCI A. M.
ACTA ONCOLOGICA TURCICA , vol.55, pp.52-57, 2022 (TRDizin)
2022
202239. Clinical Characteristics and Outcomes of COVID-19 in Turkish Patients with Hematological Malignancies
CİVRİZ BOZDAĞ S., CENGİZ SEVAL G., Hindilerden I. Y., Hindilerden F., ANDIÇ N., BAYDAR M., et al.
TURKISH JOURNAL OF HEMATOLOGY
, vol.39, no.1, pp.43-54, 2022 (SCI-Expanded, Scopus, TRDizin)
2021
202140. Infections in hematopoietic stem cell transplant patients admitted to Hematology intensive care unit: a single-center study.
Barlas T., Inci K., AYGENCEL BIKMAZ Ş. G., TÜRKOĞLU M., GÜZEL TUNÇCAN Ö., Can F., et al.
Hematology (Amsterdam, Netherlands) , vol.26, no.1, pp.328-339, 2021 (SCI-Expanded, Scopus)
2021
202141. Metabolic syndrome and cardiovascular disease after haematopoietic cell transplantation (HCT) in adults: an EBMT cross-sectional non-interventional study
Greenfield D. M., Salooja N., Peczynski C., van der Werf S., Schoemans H., Hill K., et al.
BONE MARROW TRANSPLANTATION
, vol.56, no.11, pp.2820-2825, 2021 (SCI-Expanded, Scopus)
2021
202142. Brentuximab vedotin consolidation therapy after autologous stem-cell transplantation in patients with high-risk Hodgkin lymphoma: Multicenter retrospective study
Akay O. M., ÖZBALAK M. M., PEHLİVAN M., Yildiz B., UZAY A., Yigenoglu T. N., et al.
HEMATOLOGICAL ONCOLOGY , vol.39, no.4, pp.498-505, 2021 (SCI-Expanded, Scopus)
2021
202143. An interim analysis of the Turkish Myeloma Registry among patients who have received up to two lines of therapy
Sevindik O. G., ÖZKURT Z. N., Boga C., Besisik S. K., Ipek Y., GEDÜK A., et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , vol.21, 2021 (SCI-Expanded, Scopus)
2021
202144. Brentuximab Vedotin Consolidation Therapy after Autologous Stem-Cell Transplantation in Patients with High-Risk Hodgkin Lymphoma: Multi-Center Retrospective Study
Ozbalak M., Akay O. M., PEHLİVAN M., Yildiz B., UZAY A., Yigenoglu T. N., et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , vol.21, 2021 (SCI-Expanded, Scopus)
2021
202145. Hematopoietic Cell Transplant-Composite Risk (HCT-CR): A Novel Predictor of Prognosis in Acute Leukemia Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
YEGİN Z. A., ÖZKURT Z. N., DİKYAR A., AYDIN KAYNAR L., KARACAOĞLU YURDAGÜL Ö., Yagci M.
TRANSPLANTATION PROCEEDINGS
, vol.53, no.6, pp.2013-2020, 2021 (SCI-Expanded, Scopus)
2021
202146. Hematopoietic stem cell transplantation for adults with relapsed acute promyelocytic leukemia in second complete remission
Sanz J., Labopin M., Sanz M. A., Aljurf M., Sousa A. B., Craddock C., et al.
BONE MARROW TRANSPLANTATION , vol.56, no.6, pp.1272-1280, 2021 (SCI-Expanded, Scopus)
2021
202147. Autologous Hematopoietic Cell Transplantation For Relapsed Multiple Myeloma Performed With Stem Cells Re-Mobilised Following A Prior AUTO-HCT - A Retrospective Study on Behalf of EBMT CMWP
Drozd-Sokolowska J., Gras L., Zinger N., Snowden J. A., Arat M., Basak G., et al.
BONE MARROW TRANSPLANTATION , vol.56, pp.133-134, 2021 (SCI-Expanded, Scopus)
2021
202148. Determination and Role of Epstein-Barr Virus in Patients With Lymphoproliferative Disorders.
Colak M., Sarzhanova S., Yegin Z. A., Ozkurt Z. N., Fidan I., Bozdayi G.
Clinical lymphoma, myeloma & leukemia , vol.21, no.5, 2021 (SCI-Expanded, Scopus)
2021
202149. Retrospective Evaluation of Effects of Preoperative Anaemia Treatment in Gynaecological and Obstetric Surgical Patients
Gunaydin B., Işik G., Bağcaz S., Inan G., Bozkurt N., Özkurt Z. N., et al.
TURKISH JOURNAL OF ANAESTHESIOLOGY AND REANIMATION , vol.49, no.1, pp.25-29, 2021 (ESCI, Scopus, TRDizin)
2021
202150. Can treating critically-ill haematological malignancy patients in a separate intensive care unit decrease intensive care unit mortality?
AYGENCEL BIKMAZ Ş. G., BOYACI DÜNDAR N., TÜRKOĞLU M., YEGİN Z. A., ÖZKURT Z. N., YAĞCI A. M.
TURKISH JOURNAL OF MEDICAL SCIENCES
, vol.51, no.4, pp.2095-2100, 2021 (SCI-Expanded, Scopus, TRDizin)
2020
202051. Alternative donors provide comparable results to matched unrelated donors in patients with acute lymphoblastic leukemia undergoing allogeneic stem cell transplantation in second complete remission: a report from the EBMT Acute Leukemia Working Party
Brissot E., Labopin M., Russo D., Martin S., Schmid C., Glass B., et al.
BONE MARROW TRANSPLANTATION , vol.55, no.9, pp.1763-1772, 2020 (SCI-Expanded, Scopus)
2020
202052. Retrospective analysis of the association of the expression and single nucleotide polymorphisms (SNPs) of the TLR4, PTX3 and Dectin-1 (CLEC/A) genes with development of invasive aspergillosis among haematopoietic stem cell transplant recipients with oncohaematological disorders
Kalkancı A., Tuğ E., Fidan I., Güzel Tunçcan Ö., Özkurt Z. N., Yegin Z. A., et al.
MYCOSES
, vol.63, pp.832-839, 2020 (SCI-Expanded, Scopus)
2020
202053. Association of uric acid levels before start of conditioning with mortality after allogeneic hematopoietic stem cell transplantation - a prospective, non-interventional study of the EBMT Transplant Complication Working Party
Penack O., Peczynski C., van der Werf S., Finke J., Ganser A., Schoemans H., et al.
HAEMATOLOGICA
, vol.105, no.7, pp.1977-1983, 2020 (SCI-Expanded, Scopus)
2020
202054. The Impact of Pre-transplant Cell-free DNA Levels on Leukemia Relapse and Transplant-related Complications in Allogeneic Hematopoietic Stem Cell Transplant Recipients
YEGİN Z. A., Can F., GÖKÇEN S., Sadioglu R. E., ÖZKURT Z. N., İLHAN Ç., et al.
Balkan medical journal
, vol.37, no.3, pp.138-143, 2020 (SCI-Expanded, Scopus, TRDizin)
2020
202055. Association of Serum Ferritin Levels Before Start of Conditioning With Mortality After alloSCT - A Prospective, Non-interventional Study of the EBMT Transplant Complications Working Party
Penack O., Peczynski C., van der Werf S., Finke J., Ganser A., Schoemans H., et al.
FRONTIERS IN IMMUNOLOGY
, vol.11, 2020 (SCI-Expanded, Scopus)
2020
202056. Outcome in patients with diffuse large B-cell lymphoma who relapse after autologous stem cell transplantation and receive active therapy. A retrospective analysis of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation (EBMT)
Gonzalez-Barca E., Boumendil A., Blaise D., Trneny M., Masszi T., Finel H., et al.
BONE MARROW TRANSPLANTATION
, vol.55, no.2, pp.393-399, 2020 (SCI-Expanded, Scopus)
2020
202057. Investigation of JC Virus Positivity By Real-time Polymerase Chain Reaction in Patients with Hematopoietic Stem Cell Transplant
ÇOLAK M., Kocak A. A., Kaynar L. A., ÖZKURT Z. N., YEGİN Z. A., BOZDAYI G.
FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI , vol.25, no.1, pp.40-46, 2020 (ESCI, TRDizin)
2020
202058. Comparison of post-remission strategies in acute myeloid leukemia: Autologous hematopoietic stem cell transplantation versus consolidation chemotherapy
YEGİN Z. A., DİKYAR A., Kaynar L. A., Can F., ÖZKURT Z. N., Yagci M.
HEMATOLOGY REPORTS , vol.12, no.3, pp.51-54, 2020 (ESCI, Scopus)
2020
202059. Pre-transplant sTIM-3 levels may have a predictive impact on transplant outcome in acute leukemia patients
YEGİN Z. A., Can F., Aydin Kaynar L., GÖKÇEN S., Eren Sadioglu R., ÖZKURT Z. N., et al.
HEMATOLOGY , vol.25, no.1, pp.125-133, 2020 (SCI-Expanded, Scopus)
2019
201960. A prospective non-interventional study on the impact of transfusion burden and related iron toxicity on outcome in myelodysplastic syndromes undergoing allogeneic hematopoietic cell transplantation
Cremers E. M. P., de Witte T., de Wreede L., Eikema D., Koster L., van Biezen A., et al.
LEUKEMIA & LYMPHOMA
, vol.60, no.10, pp.2404-2414, 2019 (SCI-Expanded, Scopus)
2019
201961. Antilymphocyte globulin for matched sibling donor transplantation in patients with myelofibrosis
Robin M., Chevret S., Koster L., Wolschke C., Yakoub-Agha I., Bourhis J. H., et al.
HAEMATOLOGICA
, vol.104, no.6, pp.1230-1236, 2019 (SCI-Expanded, Scopus)
2019
201962. Prognostic Significance of Serum BAFF, APRIL, TACI and BCMA Levels in Chronic Lymphocytic Leukemia
Mentese I. B., YEGİN Z. A., GÖKÇEN S., ÖZKURT Z. N., Yagci M.
INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION
, vol.35, no.2, pp.265-271, 2019 (SCI-Expanded, Scopus)
2018
201863. Tuberculosis reactivation related with ruxolitinib in a patient with primary myelofibrosis
Pepeler M. S., ÖZKURT Z. N., GÜZEL TUNÇCAN Ö., AKYÜREK N.
JOURNAL OF INFECTION IN DEVELOPING COUNTRIES
, vol.12, no.10, pp.926-928, 2018 (SCI-Expanded, Scopus)
2018
201864. Secondary antifungal prophylaxis in allogeneic hematopoietic stem cell transplant recipients with invasive fungal infection
Pepeler M. S., YILDIZ Ş., YEGİN Z. A., ÖZKURT Z. N., GÜZEL TUNÇCAN Ö., ERBAŞ G., et al.
JOURNAL OF INFECTION IN DEVELOPING COUNTRIES
, vol.12, no.9, pp.799-805, 2018 (SCI-Expanded, Scopus)
2018
201865. Relationship between Epstein-Barr Virus (EBV) Infection and Viral Load in Immunosuppressive Patients
Colak M., Kocak A. A., DALGIÇ B., ÖZKURT Z. N., FİDAN I., ÖZKAN S., et al.
ISTANBUL MEDICAL JOURNAL , vol.19, no.1, pp.7-13, 2018 (ESCI, TRDizin)
2018
201866. Monoclonal B-cell lymphocytosis in blood donors in Turkey
Yagci M., YEGİN Z. A., Yenicesu I., Suyani E., Ulu B. U., Inci K., et al.
HEMATOLOGY
, vol.23, no.1, pp.25-29, 2018 (SCI-Expanded, Scopus)
2018
201867. İmmünsüpresif Hastalarda Epstein-Barr Virüs (EBV) Viral Yükü ile Klinik Tablo Arasındaki ilişkiRelationship between Epstein-Barr Virus (EBV) İnfection and Viral Load in İmmunosuppressive Patients
ÇOLAK M., koçak a., DALGIÇ B., ÖZKURT Z. N., FİDAN I., ÖZKAN S., et al.
İstanbul Med J , 2018 (TRDizin)
2018
201868. İmmunsupresif hastalarda EBV viral yükü ile klinik tablo arasında ilişki
altay koçak a., çolak m., dalgıç b., ÖZKURT Z. N., FİDAN I., ÖZKAN S., et al.
İstanbul Medical Journal , vol.19, pp.7-13, 2018 (TRDizin)
2018
201869. Capecitabine Induced Therapy Related Acute Myeloblastic Leukemia with t(10;11) (q22;q23) in a Patient with Breast Cancer
ÖZKURT Z. N., Ocal R., Pepeler M. S., Ulkuden B.
GAZI MEDICAL JOURNAL
, vol.29, no.1, pp.57-58, 2018 (ESCI, Scopus, TRDizin)
2018
201870. İmmünsüpresif Hastalarda Epstein-Barr Virüs (EBV) Viral Yükü ile Klinik Tablo Arasındaki ilişki
ÇOLAK M., ALTAY KOÇAK A., DALGIÇ B., ÖZKURT Z. N., FİDAN I., ÖZKAN S., et al.
Istanbul Medical Journal , vol.19, pp.7-13, 2018 (TRDizin)
2017
201771. Factors affecting hematopoietic stem cell mobilization and apheresis in allogeneic donors: The role of iron status
ÖZKURT Z. N., Batmaz L., YEGİN Z. A., İLHAN Ç.
TRANSFUSION AND APHERESIS SCIENCE , vol.56, no.3, pp.470-473, 2017 (SCI-Expanded, Scopus)
2017
201772. Early Prognostic Value of Monitoring Serum Free Light Chain in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation
ÖZKURT Z. N., Sucak G. T., Aki S. Z., Yagci M., Haznedar R.
CANCER INVESTIGATION , vol.35, no.3, pp.195-201, 2017 (SCI-Expanded, Scopus)
2017
201773. Assessment of soluble entothelial protein c receptor and thrombomodulin levels in newly diagnosed myeloprolipherative neoplasms
çalkaya s., YEGİN Z. A., GÜLBAHAR Ö., ma ç., ÖZKURT Z. N., ACAR K., et al.
World Clin J Med Sci , vol.1, no.2, pp.84-88, 2017 (TRDizin)
2017
201774. Acute Myeloid Leukemia Presented with Severe Erythrodermia and Dermatopathic Lymphadenitis
ÖCAL R., ÖZKURT Z. N., pepeler m. s., toker g., YAĞCI A. M.
Lösemi Lenfoma Miyelom Araştırmaları Dergisi , vol.1, no.1, pp.18-21, 2017 (TRDizin)
2017
201775. Şiddetli eritrodermi ve dermatopatik lenfadenopati ile ortaya çıkan akut myeloid lösemi olgusu
öcal r., pepeler s., toker g., ÖZKURT Z. N.
LLM Dergi , vol.1, no.1, pp.18-21, 2017 (Peer-Reviewed Journal)
2017
201776. Ferritin is a predictor of prognosis in myelodysplastic syndrome?
YEGİN Z. A., HIZAL M., EREN SADİOĞLU R., ÖZKURT Z. N., Sucak G. T.
World Clin J Med Sci , vol.1, no.2, pp.89-95, 2017 (TRDizin)
2016
201677. A Rare and Mortal infection agent in patients with hematological malignancies: Saprochaete capitata Hematolojik Maligniteli Hastalarda Nadir ve Mortal Bir Enfeksiyon Etkeni: Saprochaete capitata
Aydin Kaynar L., ÖZKURT Z. N., Ulkuden B., GÜZEL TUNÇCAN Ö., Aygencel G., AKYÜREK N., et al.
Mikrobiyoloji Bulteni
, vol.50, no.4, pp.613-620, 2016 (SCI-Expanded, Scopus, TRDizin)
2016
201678. A Randomized Study Comparing the Efficacy of Three Hepatitis B Vaccine Induction Regimens in Adult Patients with Hematological Malignancies
ÖZKURT Z. N., Suyani E., Haznedar R., Yagci M.
TURKISH JOURNAL OF HEMATOLOGY
, vol.33, no.3, pp.231-235, 2016 (SCI-Expanded, Scopus, TRDizin)
2016
201679. Is It Possible to Predict Pulmonary Complications and Mortality in Hematopoietic Stem Cell Transplantation Recipients from Pre-Transplantation Exhaled Nitric Oxide Levels?
KÖKTÜRK N., Yildirim F., AYDOĞDU M., Aki S. Z., YEGİN Z. A., ÖZKURT Z. N., et al.
TURKISH JOURNAL OF HEMATOLOGY
, vol.33, no.1, pp.34-40, 2016 (SCI-Expanded, Scopus, TRDizin)
2015
201580. Acute myocardial infarction as a finding of acute promyelocytic leukemia-related coagulation disorder
ÖZKURT Z. N., Aypar E., Sarifakiogullari S., TAÇOY G., Ozdag M., Kahraman S., et al.
BLOOD COAGULATION & FIBRINOLYSIS , vol.26, no.8, pp.949-952, 2015 (SCI-Expanded, Scopus)
2015
201581. Investigation of BK and JC virus DNA positivities by real-time polymerase chain reaction in immunosuppressive patients
Colak M., Altay A., ERTEN Y., ÖZKURT Z. N., Pynar A., Bozdayy G.
JOURNAL OF CLINICAL VIROLOGY , vol.70, 2015 (SCI-Expanded, Scopus)
2015
201582. Detection of EBV infection by real-time PCR method in immunosuppressive patients
Altay A., Colak M., DALGIÇ B., ÖZKURT Z. N., FİDAN I., BOZDAYI G.
JOURNAL OF CLINICAL VIROLOGY , vol.70, 2015 (SCI-Expanded, Scopus)
2015
201583. Prevalence of Monoclonal B Lymphocytosis in First-Degree Relatives of Chronic Lymphocytic Leukemia Patients in Turkey
Demirci T., YEGİN Z. A., Kursunoglu N., Yilmaz Z., Suyant E., ÖZKURT Z. N., et al.
TURKISH JOURNAL OF HEMATOLOGY
, vol.32, no.1, pp.29-34, 2015 (SCI-Expanded, Scopus, TRDizin)
2015
201584. Dasatinib-induced pulmonary hypertension in acute lymphoblastic leukemia: case report
TAÇOY G., Cengel A., ÖZKURT Z. N., TÜRKOĞLU S.
TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY , vol.43, no.1, pp.78-81, 2015 (ESCI, Scopus, TRDizin)
2014
201485. Factors Associated with Cytomegalovirus Reactivation Following Allogeneic Hematopoietic Stem Cell Transplantation: Human Leukocyte Antigens Might Be Among the Risk Factors
Acar K., Aki S. Z., ÖZKURT Z. N., BOZDAYI G., Rota S., Sucak G. T.
TURKISH JOURNAL OF HEMATOLOGY
, vol.31, no.3, pp.276-285, 2014 (SCI-Expanded, Scopus, TRDizin)
2014
201486. A Rare Presentation of Extramedullary Hematopoiesis in Post-polycythemic Myelofibrosis
Degertekin C. K., ÖZKURT Z. N., AKYÜREK N., Yagci M.
INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION
, vol.30, 2014 (SCI-Expanded, Scopus)
2014
201487. Relationship Between Teicoplanin Use and Increase in Minimal Inhibitor Concentrations of Coagulase-Negative Staphylococci
Güzel Tunçcan Ö., Dizbay M., Tozlu Keten D., Özkurt Z. N., Sucak G., Şenol E.
Gazi Medical Journal , vol.25, pp.97-99, 2014 (Scopus, TRDizin)
2013
201388. TCTP/HRF pathway and angiogenesis: A feasible intercourse in chronic lymphocytic leukemia
Yagci M., YEGİN Z. A., AKYÜREK N., KAYHAN H., ÖZKURT Z. N., Sucak G. T., et al.
LEUKEMIA RESEARCH , vol.37, no.6, pp.665-670, 2013 (SCI-Expanded, Scopus)
2012
201289. The prognostic role of hemochromatosis H63D allele in allogeneic hematopoietic stem cell transplantation
Sucak G. T., Yasar D. G., YEGİN Z. A., ERGÜN M. A., ÖZKURT Z. N., Aki S. Z., et al.
ANNALS OF HEMATOLOGY , vol.91, no.8, pp.1281-1287, 2012 (SCI-Expanded, Scopus)
2012
201290. Is there any relationship between pulmonary function tests and post-transplant complications of allogeneic hematopoetic stem cell transplantation?
Aydogdu M., Ozyilmaz E., Kokturk N., YEGİN Z. A., ÖZKURT Z. N., Aki Z. S., et al.
MINERVA MEDICA
, no.3, pp.189-198, 2012 (SCI-Expanded, Scopus)
2011
201191. Early post-transplantation positron emission tomography in patients with Hodgkin lymphoma is an independent prognostic factor with an impact on overall survival
Sucak G. T., ÖZKURT Z. N., Suyani E., Yasar D. G., Akdemir O. U., Aki Z., et al.
ANNALS OF HEMATOLOGY , vol.90, no.11, pp.1329-1336, 2011 (SCI-Expanded, Scopus)
2011
201192. Impact of prohepcidin levels and iron parameters on early post-transplantation toxicities
Aki S. Z., PAŞAOĞLU H., YEGİN Z. A., Suyani E., Demirtas C., ÖZKURT Z. N., et al.
HEMATOLOGY , vol.16, no.5, pp.284-290, 2011 (SCI-Expanded, Scopus)
2011
201193. Pro-oxidative/antioxidative imbalance: a key indicator of adverse outcome in hematopoietic stem cell transplantation
Yegin Z. A., Pasaoglu H., Aki S. Z., Ozkurt Z. N., Demirtas C., Yagci M., et al.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY , vol.33, no.4, pp.414-423, 2011 (SCI-Expanded, Scopus)
2011
201194. Value of F-18-fluorodeoxyglucose uptake in positron emission tomography/computed tomography in predicting survival in multiple myeloma
Haznedar R., Aki S. Z., Akdemir O. U., ÖZKURT Z. N., Ceneli O., Yagci M., et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , vol.38, no.6, pp.1046-1053, 2011 (SCI-Expanded, Scopus)
2011
201195. Gemcitabine and vinorelbine combination is effective in both as a salvage and mobilization regimen in relapsed or refractory Hodgkin lymphoma prior to ASCT
Suyani E., Sucak G. T., Aki S. Z., YEGİN Z. A., ÖZKURT Z. N., Yagci M.
ANNALS OF HEMATOLOGY , vol.90, no.6, pp.685-691, 2011 (SCI-Expanded, Scopus)
2010
201096. Abnormal protein bands in patients with multiple myeloma after haematopoietic stem cell transplantation: does it have a prognostic significance?
Sucak G., Suyani E., Ozkurt Z. N., Yegin Z. A., Aki Z., Yagci M.
HEMATOLOGICAL ONCOLOGY , vol.28, no.4, pp.180-184, 2010 (SCI-Expanded, Scopus)
2010
201097. Risk factors for fungal pulmonary infections in hematopoietic stem cell transplantation recipients: the role of iron overload
Ozyilmaz E., Aydogdu M., Sucak G., Aki S. Z., Ozkurt Z. N., Yegin Z. A., et al.
BONE MARROW TRANSPLANTATION
, no.10, pp.1528-1533, 2010 (SCI-Expanded, Scopus)
2010
201098. High ferritin levels are associated with hepatosplenic candidiasis in hematopoietic stem cell transplant candidates
GÜZEL TUNÇCAN Ö., YEGİN Z. A., ÖZKURT Z. N., ERBAŞ G., Aki S. Z., ŞENOL E., et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
, vol.14, 2010 (SCI-Expanded, Scopus)
2010
201099. The Impact of Bone Marrow Fibrosis on the Outcome of Hematopoietic Stem Cell Transplantation
Suyani E., Aki S. Z., Yegin Z. A., Ozkurt Z. N., Altindal S., Akyurek N., et al.
TRANSPLANTATION PROCEEDINGS , vol.42, no.7, pp.2713-2719, 2010 (SCI-Expanded, Scopus)
2010
2010100. Hepatitus B virus reactivation in HBV-DNA negative and positive patients with hematological malignancies
Yagci M., ÖZKURT Z. N., YEGİN Z. A., Aki Z., Sucak G. T., Haznedar R.
HEMATOLOGY , vol.15, no.4, pp.240-244, 2010 (SCI-Expanded, Scopus)
2010
2010101. Iron Overload: Predictor of Adverse Outcome in Hematopoietic Stem Cell Transplantation
Sucak G. T., Yegin Z. A., Ozkurt Z. N., Aki S. Z., Yagci M.
TRANSPLANTATION PROCEEDINGS , vol.42, no.5, pp.1841-1848, 2010 (SCI-Expanded, Scopus)
2010
2010102. Donor lymphocyte infusion for leukemia relapse after hematopoietic stem cell transplantation
YEGİN Z. A., ÖZKURT Z. N., Aki S. Z., Sucak G. T.
TRANSFUSION AND APHERESIS SCIENCE , vol.42, no.3, pp.239-245, 2010 (SCI-Expanded, Scopus)
2010
2010103. Free light chain: a novel predictor of adverse outcome in chronic lymphocytic leukemia
YEGİN Z. A., Ozkurt Z. N., Yaci M.
EUROPEAN JOURNAL OF HAEMATOLOGY , vol.84, no.5, pp.406-411, 2010 (SCI-Expanded, Scopus)
2010
2010104. Hepatitis B-related events in autologous hematopoietic stem cell transplantation recipients
Ceneli O., ÖZKURT Z. N., Acar K., Rota S., Aki S. Z., YEGİN Z. A., et al.
WORLD JOURNAL OF GASTROENTEROLOGY
, vol.16, no.14, pp.1765-1771, 2010 (SCI-Expanded, Scopus)
2010
2010105. Thrombopoietic cytokines and platelet count in multiple myeloma
ÖZKURT Z. N., Yagci M., Sucak G. T., Kirazli S., Haznedar R.
PLATELETS , vol.21, no.1, pp.33-36, 2010 (SCI-Expanded, Scopus)
2010
2010106. Factors Affecting Stem Cell Mobilization for Autologous Hematopoietic Stem Cell Transplantation
ÖZKURT Z. N., YEGİN Z. A., Suyani E., Aki S. Z., Acar K., Yagci M., et al.
JOURNAL OF CLINICAL APHERESIS , vol.25, no.5, pp.280-286, 2010 (SCI-Expanded, Scopus)
2009
2009107. Impact of ABO-Incompatible Donor on Early and Late Outcome of Hematopoietic Stem Cell Transplantation
Ozkurt Z. N., Yegin Z. A., Yenicesu I., Aki S. Z., Yagci M., Sucak G. T.
TRANSPLANTATION PROCEEDINGS
, vol.41, no.9, pp.3851-3858, 2009 (SCI-Expanded, Scopus)
2009
2009108. Diagnostic Usefulness Of Quantitative 18F-FDG PET/CT Data In The Detection Of Bone Marrow Involvement In Primary Staging Of Lymphoma Patients
Cakir T., Gokcora N., Akdemir Ü. Ö., Karabacak N., Akyurek N., Cakir A., et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , vol.36, pp.241, 2009 (SCI-Expanded, Scopus)
2009
2009109. Bortezomib-induced perivascular dermatitis in a patient with multiple myeloma
ÖZKURT Z. N., Sucak G. T., Aki S. Z., Yagci M., Erdem O.
CUTANEOUS AND OCULAR TOXICOLOGY , vol.28, no.3, pp.141-143, 2009 (SCI-Expanded, Scopus)
2009
2009110. Thrombopoietic Cytokine and P-Selectin Levels in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation: Decrease in Posttransplantation P-Selectin Levels Might Predict the Degree of Maximum Response
Aki S. Z., Sucak G. T., PAŞAOĞLU H., ÖZKURT Z. N., YEGİN Z. A., Ofluoglu E., et al.
CLINICAL LYMPHOMA & MYELOMA , vol.9, no.3, pp.229-233, 2009 (SCI-Expanded)
2009
2009111. Melanocortin-4 Receptor Gene Polymorphisms in Obese Patients
Yurtcu E., Yilmaz A., Ozkurt Z. N., Kolukisa E., Yilmaz M., KELEŞ H., et al.
BIOCHEMICAL GENETICS
, vol.47, pp.295-300, 2009 (SCI-Expanded, Scopus)
2009
2009112. Allogeneic stem cell transplantation for severe aplastic anemia: Graft rejection remains a problem
Aki S. Z., Sucak G. T., ÖZKURT Z. N., YEGİN Z. A., Yagci M., Haznedar R.
TRANSFUSION AND APHERESIS SCIENCE , vol.40, no.1, pp.5-11, 2009 (SCI-Expanded, Scopus)
2009
2009113. Extranodal multifocal Rosai-Dorfman disease: response to 2-chlorodeoxyadenosine treatment
Konca C., Oezkurt Z. N., Deger M., Aki Z., Yagci M.
INTERNATIONAL JOURNAL OF HEMATOLOGY , vol.89, no.1, pp.58-62, 2009 (SCI-Expanded, Scopus)
2009
2009114. The relationship between serum adiponectin level and anthropometry, bone mass, osteoporotic fracture risk in postmenopausal women
Ozkurt B., ÖZKURT Z. N., Altay M., Aktekin C. N., ÇAĞLAYAN O., Tabak Y.
EKLEM HASTALIKLARI VE CERRAHISI-JOINT DISEASES AND RELATED SURGERY
, vol.20, no.2, pp.78-84, 2009 (SCI-Expanded, Scopus, TRDizin)
2008
2008115. The role of liver biopsy in the workup of liver dysfunction late after SCT: is the role of iron overload underestimated?
Sucak G. T., Yegin Z. A., Oezkurt Z. N., Aki S. Z., Karakan T., Akyol G.
BONE MARROW TRANSPLANTATION
, vol.42, no.7, pp.461-467, 2008 (SCI-Expanded, Scopus)
2008
2008116. Impact of adiponectin on left ventricular mass index in non-complicated obese subjects
Ebinc H., Ebninc F. A., ÖZKURT Z. N., DOĞRU M. T., Tulmac M., Yilmaz M., et al.
ENDOCRINE JOURNAL
, vol.55, no.3, pp.523-528, 2008 (SCI-Expanded, Scopus)
2008
2008117. Cardiac systolic function in patients receiving hematopoetic stem cell transplantation: Risk factors for posttransplantation cardiac toxicity
Sucak G. T., Ozkurt Z. N., Aki Z., Yagci M., Cengel A., Haznedar R.
TRANSPLANTATION PROCEEDINGS , vol.40, no.5, pp.1586-1590, 2008 (SCI-Expanded, Scopus)
2008
2008118. Adiponectin and insulin resistance in obesity-related diseases
Ebinc H., Ozkurt Z. N., Ebin F. A., Yilmaz M., Caglayan O.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
, vol.36, no.1, pp.71-79, 2008 (SCI-Expanded, Scopus)
2008
2008119. Effects of sympatholytic therapy with moxonidine on serum adiponectin levels in hypertensive women
Ebinc H., Ozkurt Z. N., Ebin F. A., Ucardag D., Caglayan O., Yilmaz M.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
, vol.36, no.1, pp.80-87, 2008 (SCI-Expanded, Scopus)
2007
2007120. Treatment of sinusoidal obstruction syndrome with defibrotide: A single-center experience
Sucak G. T., Aki Z. S., Yagci M., Yegin Z. A., Ozkurt Z. N., Haznedar R.
TRANSPLANTATION PROCEEDINGS , vol.39, no.5, pp.1558-1563, 2007 (SCI-Expanded, Scopus)
2007
2007121. Prevalence of coeliac disease in patients with autoimmune thyroiditis in a Turkish population
Guliter S., Yakaryilmaz F., Ozkurt Z. N., Ersoy R., Ucardag D., Caglayan O., et al.
WORLD JOURNAL OF GASTROENTEROLOGY
, vol.13, no.10, pp.1599-1601, 2007 (SCI-Expanded, Scopus)
2007
2007122. Relationship of early hypertensive retinopathy to inflammation markers and microalbuminuria in hypertensive patients with regulated blood pressure
Ebinc H., Ebinc F. A., Ozkurt Z. N.
SAUDI MEDICAL JOURNAL , vol.28, no.3, pp.472-473, 2007 (SCI-Expanded, Scopus)
2007
2007123. Frequency of microalbuminuria and its relationship with other atherosclerotic risk factors in nondiabetic hypertensive patients
ÖZKURT Z. N., fatma e., KELEŞ H., EBİNÇ H., GÜLİTER S.
Anadolu Kardiyoloji Dergisi , 2007 (TRDizin)
2006
2006124. Frequencies of serum antibodies to Helicobacter pylori CagA and VacA in a Turkish population with various gastroduodenal diseases
Sezikli M., Guliter S., Apan T. Z., Aksoy A., Keles H., Ozkurt Z. N.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
, vol.60, no.10, pp.1239-1243, 2006 (SCI-Expanded, Scopus)
2006
2006125. Relationship of left ventricular mass to insulin sensitivity and body mass index in healthy individuals
Ebinc H., Ayerden Ebinc F., Nur Ozkurt Z. N., Dogru T., Yilmaz M.
ACTA CARDIOLOGICA
, vol.61, no.4, pp.398-405, 2006 (SCI-Expanded, Scopus)
2005
2005126. Risedronate-induced intravascular haemolysis complicated by acute tubular necrosis
Ozkurt Z. N., Guliter S., Keles I., Keles H.
CLINICAL RHEUMATOLOGY , vol.24, no.6, pp.665-666, 2005 (SCI-Expanded, Scopus)
2005
2005127. The relationship between atherosclerotic risk factors and carotid atherosclerosis in hemodialysis and peritoneal dialysis patients
Ozkurt Z. N., Bali M., Guz G., Ozdemir H., Cevik C., Sindel S.
DIALYSIS & TRANSPLANTATION , vol.34, no.12, pp.854-859, 2005 (SCI-Expanded, Scopus)
2005
2005128. Intravenous iron therapy as a possible risk factor for atherosclerosis in end-stage renal disease
Altok K., Guz G., Ozdemir H., Erten Y., Atalay V., Bicik Z., et al.
INTERNATIONAL HEART JOURNAL
, vol.46, no.2, pp.255-264, 2005 (SCI-Expanded, Scopus)
Papers Presented at Peer-Reviewed Scientific Conferences
2025
20251. Prognostic analysis of salvage allogeneic HSCT in acute leukemia patients relapsing after autologous HCT: a study from the acute leukemia working party of EBMT
Kulağın A., Remenyi P., Wallet H., Latour R., Broers A., Aljurf M., et al.
American Society of Hematology, Florida, United States Of America, 5 - 09 December 2025, pp.1, (Summary Text)
2025
20252. MİYELOFİBROZİSTE RUKSOLİTİNİBİN GERÇEK YAŞAM ETKİLİLİĞİ VE GÜVENLİLİĞİ: ÇOK MERKEZLİ KOHORT ÇALIŞMASI (CHART-MF)
Türkiye Mf Çalışma Grubu M., Özkurt Z. N.
ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Turkey, 28 October - 02 November 2025, pp.184-185, (Summary Text)
2025
20253. EFFECTS OF DIOSCIN ON NLRP3 INFLAMMOSOME EXPRESSION AND APOPTOSIS IN CHRONIC LYMPHOCYTIC LEUKEMIA CELLS
Gökçen S., Kayhan H., Yegin Z. A., Özkurt Z. N., Yağcı A. M.
19TH INTERNATIONAL CONGRESS OF IMMUNOLOGY, Vienna, Austria, 17 - 22 August 2025, (Full Text)
2025
20254. HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS STEM CELL TRANSPLANTATION IN HODGKIN LYMPHOMA: A MULTICENTER REAL-WORLD ANALYSIS FROM TURKEY
ERDOĞAN YÖN M. E., SAVAŞ E. M., DUMLUDAĞ B., YILDIZ Ş., YILDIRIM M., YEGİN Z. A., et al.
EHA 2025 ANNUAL MEETING, Italy, 12 - 15 June 2025, (Full Text)
2025
20255. ALLOJENEİK HEMATOPOETİK KÖK HÜCRE NAKLİ YAPILAN HASTALARDA VİRAL SOLUNUM YOLU ENFEKSİYONLARINA BÜTÜNCÜL BİR BAKIŞ: KLİNİK ÖZELLİKLER, RİSK FAKTÖRLERİ VE PROGNOZ
YEGİN Z. A., ÇALIŞKAN E., YILDIZ Ş., SAVAŞ E. M., KÖK YILMAZ M. İ., ÖZKURT Z. N., et al.
17. ULUSAL KEMİK İLİĞİ TRANSPLANTASYONU VE HÜCRESEL TEDAVİLER KONGRESİ, Turkey, 17 - 19 April 2025, (Full Text)
2025
20256. DAY +100 BONE MARROW MEGAKARYOCYTE RESERVE PREDICTS SURVIVAL IN PATIENTS WITH MYELODYSPLASTIC SYNDROME AND ACUTE LEUKEMIA UNDERGOING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
YEGİN Z. A., YILDIZ Ş., SAVAŞ E. M., ŞEKER A., UYAR GÖÇÜN F. P., ÖZKURT Z. N., et al.
The 51st Annual Meeting of the European Society for Blood and Marrow Transplantation: Physicians – Poster Session, Italy, 30 March - 02 April 2025, (Full Text)
2023
20237. DOES THE CONSOLIDATION TREATMENT EFFICIENT AFTER HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS STEM CELL TRANSPLANTATION IN MYELOMA PATIENTS? WHICH REGIMEN IS FEASIBLE?
ÖZKURT Z. N., YILDIZ Ş., DEMİREZEN A., YEGİN Z. A., YAĞCI A. M.
49th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, ELECTR NETWORK, 23 - 26 April 2023, pp.484-485, (Summary Text)
2023
20238. ECP VERSUS RUXOLITINIB IN STEROID-REFRACTORY ACUTE GVHD - A RETROSPECTIVE STUDY BY THE EBMT TRANSPLANT COMPLICATIONS WORKING PARTY
Penack O., Peczynski C., Boreland W., Lemaitre J., Afanasyeva K., Kornblit B., et al.
49th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, ELECTR NETWORK, 23 - 26 April 2023, pp.290-291, (Summary Text)
2023
20239. PROGNOSTIC IMPACT OF LOW SERUM MAGNESIUM LEVELS IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
Savaş E. M., Yegin Z. A., Kök M. İ., Karayel H. T., Özkurt Z. N., Bozer M. N., et al.
49th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, ELECTR NETWORK, 23 - 26 April 2023, pp.364, (Summary Text)
2023
202310. EVALUATION OF COVID-19 VACCINE ANTIBODY RESPONSES IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS: USING RUXOLUTINIB OR IBRUTINIB NEGATIVELY EFFECTS VACCINE ANTIBODY RESPONSES P 364
SAVAŞ E. M., YILDIZ Ş., ÖZKURT Z. N., BALTACI Z., GÜZEL TUNÇCAN Ö., YEGİN Z. A., et al.
49th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, Paris, France, 23 - 26 April 2023, vol.58, pp.299-300, (Summary Text)
2023
202311. A Treatment Option in the Acute GVHD: Mesenchymal Stem Cell Therapy
Çalışkan E., Soyugür A., Özkurt Z. N., Yegin Z. A., Adışen E.
8th International Dermatology & Cosmetology Congress- INDERCOS, İstanbul, Turkey, 9 - 12 March 2023, pp.121-122, (Full Text)
2022
202212. İnvaziv Pulmoner Aspergilloz Şüpheli Hastalarda Galaktomannan ve Beta Glukan Antijen Testlerinin Karşilaştir
ÇUHADAR T., KALKANCI A., GÜZEL TUNÇCAN Ö., YEGİN Z. A., ÖZKURT Z. N., KÖKTÜRK N., et al.
XL. ULUSLARARASI TÜRK MIKROBIYOLOJI KONGRESI, Turkey, 16 November 2022, (Full Text)
2022
202213. The impact of thrombopoietin receptor agonists on bone marrow fibrosis in allogeneic stem cell transplant recipients
BOSTANKOLU DEĞİRMENCİ B., YEGİN Z. A., DİKYAR A., AYDIN KAYNAR L., ÖZKURT Z. N., UYAR GÖÇÜN F. P., et al.
The 48th Annual Meeting of the European Society for Blood and Marrow Transplantation, 19 - 23 March 2022, vol.57, pp.362-363, (Summary Text)
2022
202214. Thiotepa-based reduced intensity conditioning are a valid alternative to total-body irradiation-based regimens in patients with acute lymphoblastic leukemia: A study of the alwp of the ebmt
Battıpaglıa G., L M., L S., R A., Özkurt Z. N., B J., et al.
the 48th Annual meeting of tha European Blood and Marrow Transplantation, Praha, Czech Republic, 19 - 23 March 2022, vol.57, no.100416, pp.163-164, (Summary Text)
2022
202215. The impact of thrombopoirtin receptor agonists on bone marrow fibrosis in allogeneic stem cell transplantaion recipients
Bostankolu Değirmenci B., Yegin Z. A., Dikyar A., Aydın Kaynar L., Özkurt Z. N., Uyar Göçün F. P., et al.
The 48 th Annual Meeting of the European Blood and Marrow, Praha, Czech Republic, 19 - 23 March 2022, vol.57, no.100416, pp.362-363, (Summary Text)
2021
202116. MULTİPL MYELOMLU HASTADA OKHN KARARINDA KAPSAMLI GERİATRİK TESTLERİN ROLÜ VE ZAMANLAMASI NE OLMALIDIR? PROSPEKTİF ANALİZ
DURMUŞ DEMİREL K., ÖZKURT Z. N., TUNA DOĞRUL R., AYDIN KAYNAR L., YEGİN Z. A., GÖKER B., et al.
47.Ulusal Hematoloji Kongresi, Antalya, Turkey, 4 - 07 November 2021, pp.216-217, (Full Text)
2021
202117. THE PROCESS OF SARS-COV-2 PCR POSITIVITY IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES
Altay Koçak A., Güzel Tunçcan Ö., Büyükkoruk M., Dikyar A. A., Sarzhanova S., Özkurt Z. N., et al.
ESCV, 15 - 17 September 2021, pp.126, (Full Text)
2021
202118. SeçilmişTirotoksikoz Olgularında Plazmaferez Tedavisi- Tek Merkez Deneyimi
Kahraman S. S., Yıldız B., Yalçın M. M., Sel A. T., Dikyar A., Eroğlu Altınova A., et al.
42. Endokrinoloji ve Metabolizma Hastalıkları Kongresi, 19 - 23 May 2021, pp.633, (Summary Text)
2020
202019. The determinative role of patient-controlled-analgesia (PCA) in the early course of allogeneic hematopoietic stem cell transplantation
haşimoğlu k., can f., TERTEMİZ O. F., DİKYAR A., AKÇALI D. T., ÖZKURT Z. N., et al.
46th Annual meeting of European Society for Blood Marrow Transplantation: Physician Poster Session, United Kingdom, 29 August - 01 September 2020, vol.55, pp.181-714, (Summary Text)
2020
202020. Gebelik ve Covid 19 ile tetiklenen TTP : Olgu Sunumu
AYDIN KAYNAR L., DİKYAR A., YEGİN Z. A., ÖZKURT Z. N., YAĞCI A. M.
Hematoloji Uzmanlık Derneği Ulusal Kongresi, Turkey, 12 - 15 December 2020, (Full Text)
2020
202021. Comparison of pre-transplant Comorbidity Indices in Acute Leukemia Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
YEGİN Z. A., DİKYAR A., AYDIN KAYNAR L., ÖZKURT Z. N., YAĞCI A. M.
The 46th Annual Meeting of the European Society for Blood and Marrow Transplantation, 29 August - 01 September 2020, vol.55, pp.190-191, (Summary Text)
2020
202022. Allojeneı̇k Kök Hücre Naklı̇ Yapılan Hastalarda Trombopoetı̇n Reseptör Agonı̇stı̇ Tedavı̇sı̇ Ve Kemı̇k İlı̇ğİ Fı̇brozı̇sı̇ İlişkisi
BOSTANKOLU DEĞİRMENCİ B., DİKYAR A., AYDIN KAYNAR L., ÖZKURT Z. N., YEGİN Z. A.
46. Ulusal Hematoloji Kongresi, Turkey, 28 - 31 October 2020, pp.119, (Full Text)
2020
202023. Covid-19 enfeksiyonunun hematolojik maligniteli hastalar üzerine etkileri
AYDIN KAYNAR L., GÜZEL TUNÇCAN Ö., DİKYAR A., BOSTANKOLU DEĞİRMENCİ B., YEGİN Z. A., ÖZKURT Z. N., et al.
46. Ulusal Hematoloji Kongresi, Turkey, 28 - 31 October 2020, (Full Text)
2020
202024. Can Bone Marrow Cells Be Differentiated and Counted Using a Novel Hematology Analyzer?
KAYA Z., ÖZKURT Z. N., YAĞCI A. M., KOÇAK Ü.
ISTH 2020, Venedik, Italy, 12 July 2020, (Full Text)
2020
202025. ALLOJENEİK NAKİLDE PROFİLAKTİK G-CSF KULLANIMININ ERKEN KOMPLİKASYONLAR, AKUT VE KRONİK GVHH’NA ETKİSİ VAR MIDIR?
ÖZKURT Z. N., AYDIN KAYNAR L., DİKYAR A., CAN F., YEGİN Z. A., GÖRAL Ş., et al.
12. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, 5 - 07 March 2020, (Summary Text)
2020
202026. MULTİPL MYELOMDA DONDURULMAMIŞ ÜRÜN İLE EŞ ZAMANLI OTOLOG KÖK HÜCRE NAKLİ İLE STANDART UYGULAMANIN KARŞILAŞTIRILMASI
ÖZKURT Z. N., DİKYAR A., YEGİN Z. A., AYDIN KAYNAR L., ATEŞ E., KARACAOĞLU YURDAGÜL Ö.
12. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Muğla, Turkey, 05 March 2020, pp.54, (Full Text)
2020
202027. OKHN UYGULANMIŞ YÜKSEK RİSKLİ HL’DE BRENTUKSİMABVEDOTİN KONSOLİDASYONU GERÇEK YAŞAM VERİLERİ:ÇOK MERKEZLİ ÇALIŞMA
AKAY O. M., ÖZBALAK M. M., YILDIZ B., PEHLİVAN M., YİĞENOĞLU T., UZAY A., et al.
12. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Turkey, 5 - 07 March 2020, pp.46, (Summary Text)
2020
202028. Erişkin hemofili hastalarımızın analizi:Tek merkez deneyimi
AYDIN KAYNAR L., ÖZKURT Z. N., YEGİN Z. A., DİKYAR A., YAĞCI A. M.
Hemofili vakalarla eğitim sempozyumu, Turkey, 21 - 23 February 2020, (Full Text)
2020
202029. TOTAL VÜCUT IŞINLAMALI HAZIRLIK REJİMİ VERİLEN ERİŞKİN KÖK HÜCRE NAKLİ HASTALARINDA DEFİBROTİD PROFİLAKSİSİ ETKİN MİDİR?
DİKYAR A., ÖZKURT Z. N., YEGİN Z. A., AYDIN KAYNAR L., İLHAN Ç.
12. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Muğla, Turkey, 5 - 07 March 2020, pp.60, (Full Text)
2019
201930. “Infections in Hematopoietic Stem Cell Transplantation Patients Admitted to Hematology Intensive Care Unit in Gazi University Hospital”
BARLAS T., AYGENCEL BIKMAZ Ş. G., TÜRKOĞLU M., CAN F., AYDIN KAYNAR L., ÖZKURT Z. N., et al.
16. Ulusal Dahili ve Cerrahi Bilimler Yoğun Bakım Kongresi, 8. Avrasya Yoğun Bakım Toplantısı, ANTALYA, 13 - 16 November 2019, vol.10, pp.66-67, (Full Text)
2019
201931. “Evaluation of Colistin-induced nephrotoxicity in critically-ill haematology patients”
AYGENCEL BIKMAZ Ş. G., TÜRKOĞLU M., CAN F., AYDIN KAYNAR L., ÖZKURT Z. N., YEĞİN Z. A., et al.
16. Ulusal Dahili ve Cerrahi Bilimler Yoğun Bakım Kongresi, 8. Avrasya Yoğun Bakım Toplantısı, ANTALYA, 13 - 16 November 2019, vol.10, pp.47-48, (Full Text)
2019
201932. Infections in Hematopoietic StemCel Transplantation Patients Admitted to Hematology Intensive Care Unit in Gazi University Hospital
Barlas T., Aygencel Bıkmaz Ş. G., Türkoğlu M., Can F., Aydın Kaynar L., Özkurt Z. N., et al.
16. Ulusal Dahili ve Cerrahi Bilimler Yoğun Bakım Kongresi, 8. Avrasya Yoğun Bakım Toplantısı, Antalya, Turkey, 13 - 16 November 2019, vol.10, pp.66-67, (Full Text)
2019
201933. Safety and Efficacy of Autologous Stem Cell Transplantation in Dialysis-Dependent Myeloma Patients – the Diadem Study from the Chronic Malignancies Working Party of the EBMT
Anna W., Wang J., Wreede L., Sirait T., ÖZKURT Z. N., Snowden J., et al.
61th ASH Annual Meeting, 7 - 10 December 2019, (Summary Text)
2019
201934. OTOLOG KÖK HÜCRE NAKLİ ÖNCESİ KAPSAMLI GERİATRİK DEĞERLENDİRME YOL GÖSTERİCİ MİDİR?
KESTANE M., CAN F., DENİZ O., DİKYAR A., GÖKER B., YEGİN Z. A., et al.
45. Ulusal Hematoloji Kongresi, 30 October - 02 November 2019, (Summary Text)
2019
201935. Prognostic impact of pre-transplant TIM3 levels on transplant outcome in acute leukemia patients
YEGİN Z. A., Can F., Kaynar L. A., GÖKÇEN S., Sadioglu R. E., ÖZKURT Z. N., et al.
45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Frankfurt, Germany, 24 - 27 March 2019, vol.54, pp.161-162, (Summary Text)
2019
201936. Impact of vitamin D levels on peripheral stem cell mobilization in autologous hematopoietic stem cell transplant recipients
Can F., YEGİN Z. A., ÖZKURT Z. N., Akdogan O., Kaynar L. A.
45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Frankfurt, Germany, 24 - 27 March 2019, vol.54, pp.591-592, (Summary Text)
2019
201937. THE IMPACT OF PRE-TRANSPLANT CELL-FREE DNA LEVELS ON LEUKEMIA RELAPSE AND TRANSPLANT RELATED COMLICATIONS IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
YEGİN Z. A., CAN F., GÖKÇEN S., SADİOĞLU R. E., ÖZKURT Z. N., İLHAN Ç., et al.
24th European Hematology Association (EHA) Congress, Amsterdam, Netherlands, 13 - 16 June 2019, (Summary Text)
2019
201938. The impact of Pre-Transplant Cell-Free DNA levels on leukemia relapse and transplant related complications in allogeneic hematopoetic stem cell transplant recipients
YEGİN Z. A., CAN F., GÖKÇEN S., EREN SADİOĞLU R., ÖZKURT Z. N., İLHAN Ç., et al.
24th Congress of the European Hematology Association, Amsterdam, Netherlands, 13 - 16 June 2019, (Summary Text)
2019
201939. Hyperlactatemia, lactate clearance and outcome in critically ill patients with hematological malignancies
İNCİ K., GÖKÇE O., TÜRKOĞLU M., YAĞCI A. M., ÖZKURT Z. N., AYDIN KAYNAR L., et al.
22nd International Intensive Care Symposium, İstanbul, Turkey, 3 - 04 May 2019, (Summary Text)
2019
201940. COMPARISON OF CONSOLIDATION STRATEGIES IN ACUTE MYELOID LEUKEMIA: STANDARD CHEMOTHERAPYVS AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION
Dikyar A. A., Yeğin Z. A., CAN F., Kaynar L. A., ÖZKURT Z. N., YAĞCI A. M.
7th International Congress on Leukemia Lymphoma Myeloma - 2019, İstanbul, Turkey, 3 - 05 May 2019, vol.1, pp.38-39, (Full Text)
2019
201941. Comparison of consolidation strategies in acute myeloid leukemia: Standard chemotherapy vs autologous hematopoietic stem cell transplantation
DİKYAR A., YEGİN Z. A., AYDIN KAYNAR L., CAN F., ÖZKURT Z. N., YAĞCI A. M.
7Th International Congress Leukemia Lymphoma Myeloma, İstanbul, Turkey, 2 - 04 May 2019, vol.36, pp.38-39, (Full Text)
2019
201942. EFFICACY OF HIGH DOSE CHEMOTHERAPY AND AUTOLOGOUSHEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTSWITH PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA
CAN F., YEGİN Z. A., DİKYAR A., AYDIN KAYNAR L., ÖZKURT Z. N., YAĞCI A. M.
7th International Congress Leukemia Lymphoma Myeloma, 2 - 04 May 2019, (Full Text)
2019
201943. MESENCHYMAL STEM CELL INFUSION IN GRAFT VERSUS HOST DISEASE:A SINGLE CENTER EXPERIENCE
AYDIN KAYNAR L., YÜCESU E., CAN F., DİKYAR A., İLHAN Ç., ÖZKURT Z. N., et al.
7th International Congress Leukemia Lymphoma Myeloma, 02 May 2019 - 04 May 2009, (Full Text)
2019
201944. hyperlactatemia,lactate clearance and outcome in critically ill patients with hematological malignencies
İNCİ K., GÖKÇE O., TÜRKOĞLU M., YAĞCI A. M., ÖZKURT Z. N., AYDIN KAYNAR L., et al.
22nd ınternational intensive care symposium, 1 - 02 May 2019, (Full Text)
2019
201945. Second autologous hematopoietic stem cell transplant versus chemoimmunıtherapy in relapsed multiple myeloma after first transplantation : Single center data
CAN F., öcal r., AYDIN KAYNAR L., YEGİN Z. A., YAĞCI A. M., haznedar r., et al.
The 45th Annual Meeting of the European Society for Blood and Marrow Transplantation, Frankfurt, Germany, 23 - 27 March 2019, vol.54, pp.502-503, (Summary Text)
2017
201746. Management and outcome of patients with diffuse large B-Cell lymphoma relapsed after autologous hematopoietic stem cell transplantation (auto-HSCT): A retrospective analysis of the lymphoma working party (LWP) of the European Society for Blood and Marrow Transplantation (EBMT)
gonzalez e., boumendil a., blaise d., trneny m., masszi t., finel h., et al.
59th Annual Meeting Exposition, 9 - 12 December 2017, (Summary Text)
2018
201847. T HÜCRELİ BÜYÜK GRANÜLER LENFOSİTİK LÖSEMİ VE KRONİK MYEOİD LÖSEMİ BİRLİKTELİĞİ, OLGU SUNUMU
CAN F., AYDIN KAYNAR L., DİKYAR A., YAĞCI A. M., ÖZKURT Z. N., YEGİN Z. A.
44.Ulusal Hematoloji Kongresi, Antalya, Turkey, 31 October - 03 November 2018, pp.233, (Full Text)
2108
210848. ERİŞKİNDE ALL İDAME TEDAVİ YAN ETKİLERİ, YAN ETKİ YÖNETİMİ VE YAN ETKİLERİN SAĞ KALIM İLE İLİŞKİSİ
MERVE ECEM E. Y., ÖCAL R., GÖKÇEN S., YEĞİN Z. A., YAĞCI A. M., ÖZKURT Z. N.
44. ULUSAL HEMATOLOJİ KONGRESİ, Turkey, 31 October 2108 - 03 November 2018, (Summary Text)
2018
201849. Spinoserebellar Ataksili Hastada Miyelofibrozis Nedeniyle Yapılan Allojeneik Kök Hücre Nakli Sonrası Nörolojik İyileşme
Baltacı Z., Aydın Kaynar L., Yegin Z. A., Özkurt Z. N.
44. Ulusal Hematoloji Kongresi, Antalya, Turkey, 31 October - 03 November 2018, pp.368-369, (Summary Text)
2018
201850. Metabolic Syndrome Is Common Following Haematopoietic Cell Transplantation (HCT) and Is Associated with Increased Cardiovascular Disease and Second Cancers: An EBMT Cross-Sectional Non-Interventional Study
Greenfield D. M., Salooja N., Peczynski C., van der Werf S., Schoemans H., Hill K., et al.
60th Annual Meeting of the American-Society-of-Hematology (ASH), California, United States Of America, 1 - 04 December 2018, vol.132, (Summary Text)
2018
201851. Is the End Close for the Graft-Versus-Host Disease That Is a Big Problem Following Allogeneic Hematopoetic Stem Cell Transplantation?
İLHAN O., Seval G. C., ÖZKURT Z. N., Ural A. U., Ayli M., Sevindik O. G., et al.
60th Annual Meeting of the American-Society-of-Hematology (ASH), California, United States Of America, 1 - 04 December 2018, vol.132, (Summary Text)
2018
201852. Investigation of EBV infection in patients with acute lymphoblastic leukemia and lymphoma
ÇOLAK M., Sarzhanova S., ÖZKURT Z. N., YEGİN Z. A., FİDAN I., ÇAĞLAR K., et al.
21st Annual Meeting of European Society for Clinical Virology, ATİNA, Greece, 23 - 26 September 2018, (Summary Text)
2018
201853. Investigation of JCV positivity in patients with bone marrow transplant
ÇOLAK M., ALTAY KOÇAK A., Muftah H., ÖZKURT Z. N., Yeğin Z. A., BOZDAYI G.
21st Annual Meeting of European Society for Clinical Virology, Atina, Greece, 23 - 26 September 2018, (Summary Text)
2018
201854. Investigation of Epstein Barr Virus Infection in Patients with Acute Lymphoblastic Leukemia and Lymphoma
ÇOLAK M., SARZHANOVA S., ÖZKURT Z. N., FİDAN I., ÇAĞLAR K., BOZDAYI G.
21th Annual Meeting of the European Society for Clinical Virology Congress (ESCV), 23 - 26 September 2018, (Summary Text)
2018
201855. Upper extremity aerobic exercise training improves exercise capacity in stem cell recipients
Bargi G., Guclu M., Özkurt Z. N., Yagci M.
28th International Congress of the European-Respiratory-Society (ERS), Paris, France, 15 - 19 September 2018, vol.52, (Summary Text)
2018
201856. In vivo T-cell depletion in patients with myelofibrosis transplanted from an HLA matched sibling donor: an EBMT study
Robin M., Chevret S., Koster L., Wolschke C., Yakoubagha I., Bourhis J., et al.
44th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Lisbon, Portugal, 18 - 21 March 2018, vol.53, pp.49-51, (Summary Text)
2018
201857. Exercise capacity, physical activity, quality of life in newly diagnosed hematologic malignancies
Çelik Z., Guclu M., Özkurt Z. N.
28th International Congress of the European-Respiratory-Society (ERS), Paris, France, 15 - 19 September 2018, vol.52, (Summary Text)
2018
201858. Determinants of physical inactivity in hematopoietic stem cells recipients
Bargi G., Guclu M., Özkurt Z. N., Yagci M.
28th International Congress of the European-Respiratory-Society (ERS), Paris, France, 15 - 19 September 2018, vol.52, (Summary Text)
2018
201859. Exercise capacity, muscle strength and quality of life in physical active and inactive hematopoietic stem cells recipients
Barğı G., Boşnak Güçlü M., Özkurt Z. N., Yağcı A. M.
1st International Congress on Physiotechnotherapy, Sarajevo, Bosnia And Herzegovina, 9 - 13 May 2018, (Summary Text)
2018
201860. Exercise capasity, muscle strength and quality of life in physical active and inactive hematopoietic stem cell recipients
bağrı g., güçlü m. b., ÖZKURT Z. N., YAĞCI A. M.
international Congress on Physiotechnoyherapy, Bosnia And Herzegovina, 9 - 13 May 2018, pp.43, (Full Text)
2018
201861. Two antigens mismatch sibling donor against 9/10 B Antigen incompatible donor: Which one to choose?
CAN F., ÖZKURT Z. N., YEGİN Z. A.
6. Best of ASBMT/CIBMTR Tandem Meetings International Symposium, 13 - 15 April 2018, (Summary Text)
2018
201862. Hematopoetik Kök Hücre Nakli Alıcılarında Üst Ekstremite Aerobik Egzersiz Eğitiminin Kardiyopulmoner Sonuç Ölçümleri Üzerine Etkileri
Barğı G., Boşnak Güçlü M., Özkurt Z. N., Yağcı A. M.
Türk Toraks Derneği 21. Yıllık Kongresi, Antalya, Turkey, 11 - 15 April 2018, (Summary Text)
2017
201763. Management and Outcome of Patients with Diffuse Large B-Cell Lymphoma Relapsed after Autologous Hemopoietic Stem Cell Transplantation (auto-HSCT): A Retrospective Analysis of the Lymphoma Working Party (LWP) of the European Society for Blood and Marrow Transplantation (EBMT)
Gonzalez-Barca E., Boumendil A., Blaise D., Trneny M., Masszi T., Finel H., et al.
59th Annual Meeting of the American-Society-of-Hematology (ASH), Georgia, United States Of America, 9 - 12 December 2017, vol.130, (Summary Text)
2017
201764. Allojeneik Kök Hücre Nakli Sonrası Masif Cilt Altı Amfizem Ve Pnömomediastinum Gelişen Bir Pulmoner Mukormikozis Olgusu
CAN F., BEDİR KESER G., YILDIZ G., YEGİN Z. A., GÜZEL TUNÇCAN Ö., ERBAŞ G., et al.
43. Ulusal Hematoloji Kongresi, Turkey, 1 - 04 November 2017, (Summary Text)
2017
201765. İBRUTİNİBE YANIT ALINAN İKİ REFRAKTER B HÜCRELİ LENFOMA OLGUSU
AYDIN KAYNAR L., CAN F., ÇAKMAK G., ÖZKURT Z. N., YEGİN Z. A., YAĞCI A. M.
43. Ulusal Hematoloji Kongresi, Turkey, 1 - 04 November 2017, (Summary Text)
2017
201766. Myelodisplastik sendrom prognostik skorlama sistemleri ve diğer risk faktörlerinin geriye dönük test edilmesi
CAN F., PEPELER M. S., ÇAKMAK G., Ülküden B., ÖZKURT Z. N., YEGİN Z. A., et al.
43. Ulusal Hematoloji Kongresi, 1 - 04 November 2017, (Summary Text)
2017
201767. Otolog Hematopoetık KöK Hücre Naklı̇nde Proflaktı̇k G-Csf Kullanımı Komplı̇kasyonları Azalttı Mı?
AYDIN KAYNAR L., ÖZKURT Z. N., YEGİN Z. A., GÜZEL TUNÇCAN Ö., YAĞCI A. M., HAZNEDAR R.
43.Ulusal Hematoloji Kongresi, Antalya, Turkey, 1 - 04 November 2017, pp.50-51, (Full Text)
2017
201768. CD30 + LENFOMALI OLGULARDA BRENTÜKSİMAB VEDOTİN TEDAVİSİ SONUÇLARININ DEĞERLENDİRİLMESİ: TEK MERKEZ DENEYİMİ
AYDIN KAYNAR L., ÖZKURT Z. N., YEGİN Z. A., YAĞCI A. M.
43.Ulusal Hematoloji Kongresi, Antalya, Turkey, 1 - 04 November 2017, pp.53-54, (Full Text)
2017
201769. KRONİK MYELOSİTER LÖSEMİLİ HASTALARDA İMATİNİB TEDAVİSİNİN KESİLMESİ:ÇOK MERKEZLİ, İLERİYE DÖNÜK ÇALIŞMA 2.YIL SONUÇLARI
ÖZKURT Z. N., KARAKUŞ S., ÖCAL R., PEPELER M. S., GÖKÇEN S., YAĞCI A. M.
43. ULUSAL HEMATOLOJİ KONGRESİ, Turkey, 1 - 04 November 2017, (Summary Text)
2017
201770. Hematopoetik Kök Hücre Nakli Alıcılarında Fiziksel Aktivite Seviyesi, Egzersiz Kapasitesi Ve Yaşam Kalitesi
BARĞI G., BOŞNAK GÜÇLÜ M., ÖZKURT Z. N., YAĞCI A. M.
43. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Turkey, 1 - 04 November 2017, (Summary Text)
2017
201771. Kronik Lenfositik Lösemi Patofizyolojisinde Nükleolin: Bir Apopitoz Belirteci Olabilir mi?
YEGİN Z. A., Pepeler S., KAYHAN H., ÖZKURT Z. N., GÖKÇEN S., YAĞCI A. M.
43. Ulusal Hematoloji Kongresi, Turkey, 1 - 04 November 2017, (Summary Text)
2017
201772. Esansiyel Trombositoz ve Primer Myelofibrozisli Hastalarda Kalretikülin Mutasyonu ve Kemik İliği Fibrozisi İlişkisi
ÇAKMAK G., KAYHAN H., GÖKÇEN S., ÖZKURT Z. N., YEGİN Z. A., HAZNEDAR R., et al.
43. Ulusal Hematoloji Kongresi, Turkey, 1 - 04 November 2017, (Summary Text)
2017
201773. Pulmonary functions, respiratory muscle strength and endurance in patients with newly diagnosed hematologic malignancy
ÇELİK Z., BOŞNAK GÜÇLÜ M., ÖZKURT Z. N.
43. ULUSAL HEMATOLOJİ KONGRESİ, Turkey, 1 - 04 November 2017, (Summary Text)
2017
201774. KRONİK KARACİĞER GREFT VERSUS HOST HASTALIĞINDA FİBROZİS DEĞERLENDİRMESİNDE ELASTOGRAFİNİN ROLÜ
PEPELER M. S., YEGİN Z. A., ÖZKURT Z. N., ÖZHAN OKTAR S., AKYOL G.
43. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Turkey, 1 - 04 October 2017, (Full Text)
2017
201775. Parvovirus B19 DNA Positivity in patients attended to a university hospital in Ankara, Turkey in 3 years process
ALTAY KOÇAK A., ÖZKURT Z. N., KARÇAALTINCABA D., BOZDAYI G.
20th Annual Meeting of the European Society for Clinical Virology, Stresa, Italy, 13 - 16 September 2017, (Summary Text)
2017
201776. Comparison of matched-unrelated donors versus alternative donor (9/10) unrelated donor, cord blob unit and haplo-identical donor) in allogeneic stem cell transplantation (allo-SCT) for acute lymphoblastic leukemia (ALL) in CR2: a report of 841 patients from the EBMT Acute Leukemia Working Party
Brissot E., Labopin M., Russo D., Martin S., Schmid C., Glass B., et al.
43rd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Marseille, France, 26 - 29 March 2017, vol.52, (Summary Text)
2017
201777. PROGNOSTIC SIGNIFICANCE OF SERUM BAFF, APRIL, TACI AND BCMA LEVELS IN CHRONIC LYMPHOCYTIC LEUKEMIA
Mentese I. B., Yegin Z. A., Gokcen S., Ozkurt Z. N., Yagci M.
22nd Congress of the European-Hematology-Association, Madrid, Spain, 22 - 25 June 2017, vol.102, pp.720, (Summary Text)
2017
201778. Erişkin yeni tanılanan akut lösemi hastalarında dispne, solunum fonksiyonları, depresyon ve yaşam kalitesi
BARĞI G., DÜNDAR Z. P., ÇELİK Z., ÖZKURT Z. N., BOŞNAK GÜÇLÜ M.
Türk Toraks Derneği 20. Yıllık Kongresi, Antalya, Turkey, 5 - 09 April 2017, (Summary Text)
2017
201779. Hematolojik maliniteli hastalarda solunum fonksiyonları, egzersiz kapasitesi, solunum kas kuvveti, aktivite dispnesi ve yorgunluğun sağlıklılarda karşılaştırılması
ÇELİK Z., BARĞI G., ÖZKURT Z. N., BOŞNAK GÜÇLÜ M.
Türk Toraks Derneği 20. Yıllık Kongresi, Antalya, Turkey, 5 - 09 April 2017, (Summary Text)
2016
201680. An Alternative Donor Is a Valid Option Compared to a Matched-Unrelated in Allogeneic Stem Cell Transplantation for Acute Lymphoblastic Leukemia in CR2: A Report of 841 Patients from the EBMT Acute Leukemia Working Party
Brissot E., Labopin M., Russo D., Martin S., Schmid C., Glass B., et al.
58th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), California, United States Of America, 3 - 06 December 2016, vol.128, (Summary Text)
2016
201681. Abstract 3497 An Alternative Donor Is a Valid Option Compared to a Matched Unrelated in Allogeneic Stem Cell Transplantation for Acute Lymphoblastic Leukemia in CR2 A Report of 841 Patients from the EBMT Acute Leukemia Working Party
Brissot E., myriam L., domenio r., sonja m., christoph s., bertram g., et al.
American Society of Hematology, 3 - 06 December 2016, (Summary Text)
2016
201682. Kronik Myelositer Lösemili Hastalarda İmatinib Tedavisinin Kesilmesi Çok merkezli ileriye dönük bir çalışma
YAĞCI A. M., ÖZKURT Z. N., GÖKÇEN S.
42 Ulusal Hematoloji Kongresi, Turkey, 19 - 22 October 2016, (Summary Text)
2016
201683. Renal Transplantasyon Sonrası Geç Dönemde Gelişen Burkitt Lenfoma Olgusu
TURGUT H., HELVACI Ö., ÖZKURT Z. N., YEGİN Z. A., ERDEM Ö., AKYÜREK N., et al.
18.Ulusal Hipertansiyon ve Böbrek Hastalıkları Kongresi, 11 - 15 May 2016, (Summary Text)
2016
201684. Hematolojik Hastalığı Olan Bağışıklığı Baskılanmış Hastalarda Bronkoskopinin Tanısal Etkinliği
KÖKTÜRK N., YILDIRIM F., BAŞARIK AYDOĞAN B., KALKANCI A., GÜZEL TUNÇCAN Ö., AKI Ş. Z., et al.
Türk Toraks Derneği 19. Yıllık Kongresi, Antalya, Turkey, 6 - 10 April 2016, (Summary Text)
2016
201685. Secondary Antifungal Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplantation
PEPELER M. S., YILDIZ Ş., YEGİN Z. A., ÖZKURT Z. N., GÜZEL TUNÇCAN Ö., ERBAŞ G., et al.
42nd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, Valencia, Spain, 3 - 06 April 2016, vol.51, no.535, pp.398, (Summary Text)
2016
201686. ALLOJENEİK KÖK HÜCRE ALICILARINDA GELİŞEN VİRAL HEMORAJİK SİSTİT TEDAVİSİNDE CİDOFOVİR VE LEVOFLOKSASİN’İN ETKİNLİĞİ.
PEPELER M. S., KAYA A., YEGİN Z. A., ÇOLAK M., ÖZKURT Z. N., GÜZEL TUNÇCAN Ö., et al.
9. Ulusal Kemik İliği Transplantasyonu ve Kök Hücre Tedavileri Kongresi, Turkey, 03 March 2016, (Full Text)
2016
201687. Secondary Antifungal Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplantation
Pepeler M. S., Yildiz S., Yegin Z. A., Ozkurt Z. N., Tuncan O. G., Erbas G., et al.
42nd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, Valencia, Spain, 3 - 06 April 2016, vol.51, (Summary Text)
2016
201688. Allojenik kök hücre alıcılarında gelişen viral hemorajik sistit tedavisinde Cidefovir ve Levofloksasin in etkinliği
Kaya a., Yeğin Z., Çolak M., ÖZKURT Z. N., GÜZEL TUNÇCAN Ö., Dağlı G.
9. Ulusal Kemik İliği Transplantasyonu ve Kök Hücre Tedavileri Kongresi, Turkey, 3 - 05 March 2016, (Summary Text)
2016
201689. Secondary Antifungal Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplantation
Pepeler M., ÖZKURT Z. N., YILDIZ Z., YEĞİN A., GÜZEL TUNÇCAN Ö., ERBAŞ G., et al.
Hematoloji Kongresi, 1 - 04 March 2016, (Summary Text)
2015
201590. İmmünsüprese hastalarda gerçek zamanlı polimeraz zincir reaksiyonu Real Time PCR ile polyomavirus DNA pozitifliğinin araştırılması
ÇOLAK M., ALTAY A., ERTEN Y., ÖZKURT Z. N., PINAR A., BOZDAYI G., et al.
3. Ulusal klinik mikrobiyoloji kongresi, Turkey, 18 - 22 November 2015, (Summary Text)
2015
201591. İmmünsüpresif hastalarda EBV enfeksiyonunun Real Time PCR yöntemi ile gösterilmesi
ALTAY A., Çolak M., DALGIÇ B., ÖZKURT Z. N., FİDAN I., BOZDAYI G.
3. ulusal klinik mikrobiyoloji kongresi, Turkey, 18 - 22 November 2015, (Summary Text)
2015
201592. Hematolojik maligniteli hastalarda yoğun bakım mortalitesine etkili faktörler
BOYACI N., Güllü Z., ÖZKURT Z. N., YAĞCI A. M., TÜRKOĞLU M., AYGENCEL BIKMAZ Ş. G.
12. Ulusal Dahili ve Cerrahi Bilimler Yoğun Bakım Kongresi, 4. Avrasya Yoğun Bakım Toplantısı, Ankara, Turkey, 4 - 07 November 2015
2015
201593. Hematolojik maligniteli hastalar için ayrı bir yoğun bakım ünitesi gerekli midir
Boyacı N., Güllü Z., Özkurt Z. N., Yağcı A. M., Türkoğlu M., Aygencel Bıkmaz Ş. G.
12. Ulusal Dahili ve Cerrahi Bilimler Yoğun Bakım Kongresi, 4. Avrasya Yoğun Bakım Toplantısı, Ankara, Turkey, 4 - 07 November 2015, (Summary Text)
2015
201594. HEMATOLOJİK MALİNİTELİ İKİ OLGUDA SİSTEMİK SAPROCHAETE CAPİTATA ENFEKSİYONU
AYDIN KAYNAR L., ÖZKURT Z. N., GÜZEL TUNÇCAN Ö., KALKANCI A., Ülküden B., PEPELER M. S., et al.
41.Ulusal Hematoloji Kongresi, Antalya, Turkey, 21 - 24 October 2015, pp.139, (Full Text)
2015
201595. Myeloproliferatif Hastalıklarda Tanı Anı Serum SEPCR ve Trombomodulin Düzeylerinin Değerlendirilmesi
çalkaya s., Yeğin Z. A., GÜLBAHAR Ö., ÖZKURT Z. N., ACAR K., Sucak G.
41. Ulusal Hematoloji Kongresi, Turkey, 21 - 24 October 2015
2015
201596. Investigation of BK and JC virus DNA positivitiesby real time polymerase chain reaction inimmunosuppressive patients
Çolak M., Altay A., ERTEN Y., ÖZKURT Z. N., PINAR A., BOZDAYI G.
18th Annual Meeting of European Society for Clinical Virology, 9 - 12 September 2015, (Summary Text)
2015
201597. Detection of EBV infection by real time PCRmethod in immunosuppressive patients
Altay A., Çolak M., DALGIÇ B., ÖZKURT Z. N., FİDAN I., BOZDAYI G.
18th Annual Meeting of European Society for Clinical Virology, 9 - 12 September 2015, (Summary Text)
2015
201598. Detection of EBV infection by real timePCR method in immunosuppresive patients
Aylin A., Çolak M., DALGIÇ B., ÖZKURT Z. N., FİDAN I., BOZDAYI G.
18th Annual Meeting of the European Society for Clinical Virology, 9 - 12 September 2015
2015
201599. ACUTE LYMPHOBLASTIC LEUKEMIA IN A PATIENT WITH WERNER SYNDROME
PEPELER M. S., ÖCAL R., YALÇIN M. M., ÜLKÜDEN B., YEGİN Z. A., ÖZKURT Z. N.
5th International Congress on Leukemia Lympoma Myeloma Kongresi, Turkey, 29 April 2015, (Full Text)
2015
2015100. Diagnostic Yield Of Bronchoscopy In The Immunocompromised Patients With Haematological Disorders
Kokturk N., Yildirim F., Aydogan B. B., Kalkanci A., Tunccan Ö., Aki S. Z., et al.
International Conference of the American-Thoracic-Society (ATS), Colorado, United States Of America, 15 - 20 May 2015, vol.191, (Summary Text)
2014
2014101. IS IT POSSIBLE TO PREDICT PULMONARY COMPLICATINOS AND MORTALITY IN HEMATOPOETIC STEM CELL TRANSPLANT RECIPIENTS FROM PRE-TRANSPLANTATION EXHALED NITRIC OXIDE LEVELS?
KÖKTÜRK N., YILDIRIM F., AYDOĞDU M., YEGİN Z. A., ÖZKURT Z. N., SUYANİ E., et al.
3rd Combined WASOGBAL Meeting, 11th WASOG Meeting and 13th International Conference on BAL, İZMİR/KUŞADASI, Turkey, 8 - 11 October 2014, (Summary Text)
2010
2010102. Prognostic value of serum-free light chain monitoring in patients receiving autologous stem cell transplantation
Ozkurt Z. N., Haznedar R., Aki Z., Yagci M., Sucak G. T.
36th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantat/9th Meeting of the EBMT Data-Management-Group/26th Meeting of the EBMT Nurses Group/2nd EBMT Qual Management Meeting, Vienna, Austria, 21 - 24 March 2010, vol.45, (Summary Text)
2009
2009103. Diagnostic usefulness of quantitative 18 F-FDG PET/CT data in the detection of bone marrow involvement in primary staging of lymphoma patients
ÇAKIR T., AKÇORA N., AKDEMİR Ü. Ö., KARABACAK N., AKYÜREK N., ÇAKIR A., et al.
Annual Congress of the EANM 2009, Barcelona, Spain, 10 - 14 October 2009, vol.36, pp.241, (Summary Text)
2009
2009104. THROMBOPOIETIC CYTOKINES AND PLATELET COUNT IN MULTIPLE MYELOMA
Ozkurt Z. N., Yagci M., Acar K., Sucak G. T., Haznedar R.
14th Annual Meeting of the European-Hematology-Association, Berlin, Germany, 4 - 07 June 2009, vol.94, pp.618, (Summary Text)
2009
2009105. CONTRIBUTION OF THALIDOMIDE MAINTENANCE TO LONG TERM RESULTS OF AUTOLOGOUS STEM CELL TRANSPLANTATION IN PATIENTS WITH MULTIPLE MYELOMA
Ozkurt Z. N., Haznedar R., Yegin Z. A., Aki S. Z., Ceneli O., Yagci M., et al.
14th Annual Meeting of the European-Hematology-Association, Berlin, Germany, 4 - 07 June 2009, vol.94, pp.387, (Summary Text)
2009
2009106. ABNORMAL SERUM FREE LIGHT CHAIN RATIO AS A PREDICTOR OF ADVERSE OUTCOME IN CHRONIC LYMPHOCYTIC LEUKEMIA: HAS THE TIME COME FOR A SIMPLE PROGNOSTIC MARKER?
Yegin Z. A., Yagci M., Ozkurt Z. N., Kursunoglu N., Aki S. Z.
14th Annual Meeting of the European-Hematology-Association, Berlin, Germany, 4 - 07 June 2009, vol.94, pp.374, (Summary Text)
2009
2009107. Vinorelbine and gemcitabine as a salvage regimen prior to stem cell transplantation in refractory or relapse Hodgkin's disease
Aki Z., Sucak G., Yegin A., Ozkurt Z. N., Yagci M.
35th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation, Goteborg, Sweden, 29 March - 01 April 2009, vol.43, (Summary Text)
2009
2009108. impact of bone marrow fibrosis in the outcome of haematopoietic stem cell transplantation
Sucak G., Suyani E., Aki Z., Akyurek N., Ozkurt Z. N., Altindal S., et al.
35th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation, Goteborg, Sweden, 29 March - 01 April 2009, vol.43, (Summary Text)
2009
2009109. Adverse impact of iron overload on transplant outcome
Sucak G., Yegin Z. A., Ozkurt Z. N., Aki Z., Yagci M.
35th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation, Goteborg, Sweden, 29 March - 01 April 2009, vol.43, (Summary Text)
2008
2008110. The role of pre transplantation serum iron parameters and anti oxidative potential in early posttransplant toxicities
TURKOZ SUCAK G., AKI Ş. Z., PAŞAOĞLU H., ÖZKURT Z. N., YILMAZ-DEMİRTAŞ C., YEGİN Z. A., et al.
13th Congress of the European Hematology Association Copenhagen, Denmark, 12 - 15 June 2008
2008
2008111. THE ROLE OF PRE-TRANSPLANTATION SERUM IRON PARAMETERS AND ANTI-OXIDATIVE POTENTIAL IN EARLY POSTTRANSPLANT TOXICITIES
Sucak G. T., Aki S. Z., Pasaoglu H., Ozkurt Z. N., Demirtas C., Yegin Z. A., et al.
13th Congress of the European-Hematology-Association, Copenhagen, Denmark, 12 - 15 June 2008, vol.93, pp.325-326, (Summary Text)
2005
2005112. Relationship of serum adiponectin level, anthropometric parameters and bone mineral density in postmenopausal
Ozkurt B., Ozkurt Z. N., Altay M., Aktekin C., Caglayan O., Tabak Y.
3rd Osteoporosis and Osteoarthritis Congress, Antalya, Turkey, 20 - 24 April 2005, vol.16, pp.2198, (Summary Text)
Books
2023
20231. Lenf nodu muayenesi ve lenfadenopatiye yaklaşım
ÖZKURT Z. N.
in: İç Hastalıklarında anamnez alma ve fizik muayene, Yasemin Tekbudak Erten, Editor, Ankara Nobel Tıp Kitabevleri, Ankara, pp.269-277, 2023
2018
20182. Böbrek hastalılarında hematolojik değişiklikler
ÖZKURT Z. N.
in: HematoLog, Rauf Haznedar, Editor, Galenos, Ankara, pp.69-77, 2018
Funded Projects
2020 - 2023
2020 - 2023A Randomized, Open-label, Phase 3 Study Comparing Once-weekly vs Twice-weekly Carfilzomib in Combination With Lenalidomide and Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma (A.R.R.O.W.2)
Industrial Organizations of Other Countries Supported Project
Özkurt Z. N. (Executive)
2020 - 2021
2020 - 2021Ön tanı için yapay zeka destekli kan analiz sistemi
TUBITAK Project , 1507 - TÜBİTAK SME R&D Start Support Program
Sayınalp N.(Executive), Hayran K. M., Özkurt Z. N.
2018 - 2019
2018 - 2019İnvaziv aspergilloz ve kandidoz gelişen kök hücre nakli alıcısı hematolojik maligniteli hastalarda TLR-4, PTX-3, Dectin-1 ve CARD9 genlerindeki tek nükleotid polimorfizmlerinin ve fungal enfeksiyonlara yatkınlığın retrospektif olarak araştırılması
Project Supported by Other Private Institutions
FİDAN I., GÜZEL TUNÇCAN Ö., ÖZKURT Z. N., TUĞ E., KALKANCI A. (Executive)
2017 - 2019
2017 - 2019MK-7018, çok merkezli ulusal , gözlemsel ilaç çalışması. Hematolojik malignensisi olan yüksek riskli hastalarda antifungal profilaksi: Uygulamanın klavuzlarla karşılaştırılması
Project Supported by Other Private Institutions
Güzel Tunçcan Ö. (Executive), Metan G.(Executive), Akan H., Ulu Kılıç A., İnkaya A. Ç., Özkurt Z. N., et al.
Activities in Scientific Journals
2019 - Present
2019 - PresentTürkiye’de Lösemi Lenfoma Miyelom Araştırmaları (LLM) dergisi
Advisory Committee Member
Roles in Event Organizations
May 2022
May 20226. Gazi Hematoloji Günleri
Scientific Congress
Yağcı A. M., ÖZKURT Z. N.
Ankara, Turkey
Invited Talks
November 2024
November 2024MDS/MPN Klinisyen Gözü
Conference
50. Ulusal Hematoloji Kongresi-Turkey
November 2023
November 2023VEXAS Sendromu
Conference
Ulusal Hematoloji Kongresi 2023-Turkey
April 2023
April 2023Transplantasyon ilişkili trombotik mikroanjiopati
Conference
Ulısal Kemik iliği Transplantasyonu Kongresi-Turkey
February 2023
February 2023Ulusal standartların tanıtımı ve öz değerlendirme raporu hazırlıkları
Conference
Hematoloji Tıpta Uzmanlık Yeterlilik Kurulu (HEM-TUYEK)-Turkey
November 2022
November 2022Hematoloji Bilim Dalımız/Kliniğimiz Eğitim Programını Akredite Etmek İstiyoruz, Ne yapmalıyız?
Conference
Türk Hematoloji Derneği; 48. Ulısal Hematoloji Kongresi-Turkey
May 2022
May 2022Polistemi Vera
Conference
LLM Derneği; 2. LLM Kongresi-Turkey
March 2022
March 202210th Annual Meet the Experts of Transplanataion an Myeloma EBMT and TCT
Conference
Türk Kemik İliği Vakfı-Turkey
March 2022
March 2022Allo-HKHN Sonrası Nüks AML: Proflaksi, Pre-emptif Yaklaşım ve Tedavi
Conference
Türk Hematoloji Derneği; 14. Ulusal Kök Hücre Kongresi-Turkey
Citations
Total Citations (WOS): 1141
h-index (WOS): 19
Jury Memberships
May-2022
May 2022